City University of New York (CUNY)

CUNY Academic Works
Dissertations, Theses, and Capstone Projects

CUNY Graduate Center

9-2016

Evaluating the Effectiveness of Supervision on Trauma Training
Outcomes for Assertive Community Treatment Teams
Sacha Zilkha
The Graduate Center, City University of New York

How does access to this work benefit you? Let us know!
More information about this work at: https://academicworks.cuny.edu/gc_etds/1437
Discover additional works at: https://academicworks.cuny.edu
This work is made publicly available by the City University of New York (CUNY).
Contact: AcademicWorks@cuny.edu

Evaluating the Effectiveness of Supervision on Trauma Training Outcomes for Assertive
Community Treatment Teams

by
Sacha Zilkha

A dissertation submitted to the Graduate Faculty in Psychology in partial fulfillment of the
requirement for the degree of Doctor of Philosophy The City University of New York
2016

© 2016
Sacha Zilkha
All Rights Reserved

ii

Evaluating the Effectiveness of Supervision on Trauma Training Outcomes for Assertive
Community Treatment Teams
by
Sacha Zilkha

This manuscript has been read and accepted for the Graduate Faculty in English in satisfaction of
the dissertation requirement for the degree of Doctor of Philosophy.

____________________
Date

______________________________
Denise Hien, PhD
Chair of Examining Committee

____________________
Date

______________________________
Maureen O’Connor, PhD
Executive Officer

Supervisory Committee:
Eric Fertuck, PhD
Elliot Jurist, PhD
Diana Puñales, PhD
Philip Yanos, Phd

THE CITY UNIVERSITY OF NEW YORK

iii

ABSTRACT
Evaluating the Effectiveness of Supervision on Trauma Training Outcomes for Assertive
Community Treatment Teams
by
Sacha Zilkha
Adviser: Denise Hien, Ph.D.
Most individuals receiving mental health care do not have access to evidence-based
psychological treatments, regardless of psychological disorder. Despite the development of
effective evidence based treatments and available clinical training, clinician uptake and
adherence to such treatments has been low. In this study, the effectiveness of a trauma treatment
training model was evaluated through a quasi-experimental design to better inform and address
the gap between the existence of evidence based care and lack of evidence based treatment
options available in the community. Specifically, data from 23 Assertive Community Treatment
Teams in New York City that underwent a 1-day ICBT training along with 12-month data
collection with optional added supervision was analyzed to determine the benefits of added
supervision. Of the 23 teams, 12 opted for added supervision (i.e., Master Training). Results
indicate a potential benefit of supervisory calls on increasing the number of ICBT sessions
provided. However, teams that had added supervision did not have better clinical outcomes on
average when compared to teams that did not have the added supervision. Keywords: cognitive
behavior therapy; posttraumatic stress disorder; implementation; dissemination; Assertive
Community Treatment
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Chapter 1: Introduction to the Study
Background
Despite the availability of evidence-based psychological treatment modalities, most
individuals receiving mental health care in the public sector do not have access to evidencebased psychological care, regardless of psychological disorder. (Barlow, Bullis, Comer, &
Ametaj, 2013; Drake and Essock, 2009; Herschell, Kolko, Baumann, & Davis, 2010). For
therapists who work with individuals with complex co-occurring needs, such as co-occurring
Serious Mental Illness (SMI), Post-Traumatic Stress Disorder (PTSD) and Substance Use
Disorder (SUD), targeted interventions are particularly important because individuals with cooccurring needs have worse outcomes than individuals with singular disorders and have been
historically underserved (Fuller, 2010; McGovern et al., 2011; Mueser, Noorsday, Drake, & Fox,
2003). At the same time, many therapists in community-based settings don’t feel equipped to
treat individuals with such complex needs because of inadequate training and experience
(McGovern, Lambert-Harris, Alterman, Xie, & Meier, 2011). To better prepare clinicians in
public mental health settings who often see individuals with complex co-occurring needs, it
seems that more focused training and workforce development needs to take place in order to help
community-based clinicians learn how to effectively apply evidence-based psychological
interventions.
One way to help clinicians learn new and efficacious practices is through training and
workforce development. However, research indicates that training in Evidence-Based Practices
(EBPs) alone does not lead to the actual implementation of the practices taught (Beidas,
Edmunds, Marcus & Kendall, 2012; Herschell et al., 2010; Kolko et al., 2012; Procotor, et al.,
2009). Rather, multi-pronged approaches that incorporate on-going learning have been shown to

be more effective than training alone (Beidas et al., 2012). For example, supervision is one
critically important component that has started to show promise in terms of increasing treatment
adherence and competence among clinicians. However, research in this area is limited and the
use of supervision as part of community based training models needs to be further researched.
The following study was designed to evaluate the effectiveness of supervision on training
outcomes for Assertive Community Treatment (ACT) Teams. Specifically ACT Teams were
trained to use a specific type of Cognitive Behavioral Therapy (CBT) for individuals with
Serious Mental Illness (SMI), and co-occurring PTSD and SUD. This treatment, Integrated CBT
for PTSD and SUD has been found to be effective based on the research literature and the
following study aimed to evaluate the role of supervision and other variables on the frequency
with which ACT Teams used ICBT post-training and with supervisory supports. As such, this
study explored issues pertaining to sustainable training and supervision of evidence based
treatment implementation including workforce development and related clinical outcomes within
a special population to create increased access to EBPs in the community. Specifically, a plan
was developed that evaluated supervision as a predictor of treatment implementation among
community based mental health providers trained in ICBT.
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Chapter 2: Literature Review
Research to Practice Gap
Over the past fifteen years, increased attention has been given to what is commonly
referred to as the research to practice gap in the behavioral health field; the existence of
efficacious mental health practices in the literature compared to the use of unstandardized
psychosocial treatments offered in community settings (Hogan, 2003). Though there is growing
evidence that certain psychosocial treatments are efficacious and effective at treating certain
disorders, most individuals are not receiving evidence-based care in community mental health
settings (Barlow et al., 2013). While this is an issue for the behavioral health field, it is not
unique to human services. Motivating and initiating change within any context brings challenges
(Rogers, 2003). While there has been an abundance of evidence-based treatments developed over
the years, the research to practice gap has become more and more evident in the behavioral
health sector.
Successfully bringing “human service technologies” (e.g., Evidence Based Practices
[EBPs]) into standard practice is more complex than other types of technologies (Aarons, et al.,
2010). In the healthcare sector, original research may take up to seventeen years to yield patient
benefits (Balas, 2000). For example, in some outpatient settings, research has found that less than
ten percent of individuals with schizophrenia receive evidence based psychosocial treatments
despite the existence of such treatments (Torrey et al., 2001). Another example of the research to
practice gap is seen in the treatment of individuals with Co-Occurring Mental Health and
Substance Use Disorders (COD). Despite over fifteen years of research showing that individuals
with COD benefit most from treatment that simultaneously addresses their mental health and
substance use needs, in 2008, only seven percent of individuals with COD received treatment
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that addressed both disorders (Substance Abuse and Mental Health Administration [SAMHSA],
2008 & 2009). Again, this has been seen very recently in the availability for evidence based
services for individuals with first episode psychoses. While early intervention is a key approach
and EBPs exist to improve prognosis, there is much smaller availability of early psychosis
programs offering EBPs than the problem demands (Csillag et al., 2015).
While one may imagine that clinicians would want to provide the best treatments available
to those they serve, there are many reasons why there is such a large research practice gap. One
of the biggest challenges to closing the gap is that clinical research does not always match
clinical practice. Nonetheless evidence based practice research has moved swiftly over the last
ten years. SAMHSA’s National Registry for Evidence-based Programs and Practices (NREPP)
lists 330 interventions for a variety of mental health and substance use disorders (SAMHSA,
2014). Despite the large array of treatments to choose from however, they do not necessarily
match the needs of the community. While clinicians tend to be inclined to want to match
treatments to individual patients based on an amalgamation of needs, most evidence based
treatments are symptom specific and have taken place in laboratory settings, often leaving out
patients who have multiply occurring needs (Kazdin, 2008). This disconnect, thus, leaves
clinicians feeling skeptical as their patients differ from those being treated in the lab. And with
the hundreds of treatments to choose from in the context of an overworked and often underpaid
workforce, it is no wonder that clinicians have little motivation to seek out evidence-based
treatments for the individuals they serve.
Despite healthy skepticism that emerges from singular clinical trials that may not always
reflect the clinical populations served by practitioners, skepticism also abounds when research is
less insular, which is the case for EBPs. EBPs, unlike Empirically Supported Treatments (ESTs)
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bring together the best research and practice evidence in the field to inform clinical approaches
to care. EBPs in effect provide approaches to clinical work that includes research, clinical
expertise and client preferences (Lilienfeld et al., 2013). Thus EBPs are less insular, are based on
various studies and include clinical expertise and client preferences in a comprehensive and
meaningful way. ESTs on the other hand, are treatments that have shown themselves to be
efficacious based on two research studies where they must outperform a pill or other treatment
(Chambless & Hollon, 1998). As such, EBPs are more generalizable and better suited to the
more complex clinical needs that better represent individuals in treatment. Yet, practitioners are
still hesitant to support such practices or treatments that have been shown to be effective across
varying patient populations (Lilienfeld et al., 2013). Specifically, clinicians seem to conflate
EBPs with ESTs and cite reasons against ESTs when explaining resistance toward EBPs
generally (Lilienfeld, et al., 2013).
Since many EBPs have been manualized and in turn become a sort of EBP-based EST,
clinicians often report concerns providing treatments that seem overly mechanized, and fear that
such treatments will detract from building a healthy therapeutic alliance (Freuh, Gurbaugh,
Cusak & Elhai, 2010). These concerns, while valid, lead to resistance in learning new therapeutic
techniques. While the “dodo bird” effect has shown that when ESTs or EBPs are pitted against
each other, for the most part, no significant differences arise (Luborsky et al., 2002). For mental
health clinicians with master’s and bachelor’s levels of education these treatments that have a
research base are extremely important in bolstering clinical acumen and provide a way for nondoctoral level clinicians to practice effective forms of treatment.
Despite continuous psychotherapy research and innovations in the field, most clinicians
place a higher premium on clinical interactions with patients and learning from colleagues than
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scientific evidence in part due to unfounded fears related to EBPs (Stewart & Chambless, 2007).
In addition to the confusion between EBPs and ESTs clinicians often rely on naïve realism, or
the idea that what they perceive is in fact reality. In this way, clinicians stick strongly to the
belief that what they do works (Lilienfeld, et al., 2013). However, solely relying on individual
perceptions of patient progress is not an effective means by which to evaluate treatment
effectiveness. For example, it is a common misconception among treatment providers who
provide clinical services to individuals with SMI that the individuals they see are too sick or
uneducated to benefit from a manualized approach, while research shows otherwise (Gaag,
2014). At the same time, research shows that clinicians cannot effectively determine patient
progress or predict patient decline as well as the kinds of objective evidence used in treatment
outcome studies (Lambert et al., 2002). In fact clinicians tend to rate themselves more highly in
their patients’ clinical outcomes than is the case based on objective outcome measures (Lambert
et al., 2002).
Translational Science
To address the many barriers to bringing research into practice, researchers have begun to
focus on translation; ways of translating clinical research into clinical practice. While the basic
concept of translation has been around for at least forty years (Wolf, 1974), it is only now
becoming a major focus in the health sciences (Drolet & Lorenzi, 2011). In the mental health
sector, translational science aims to speed up the time lag between research and practice by
breaking research down into easily understood clinical practices. Translational science is
biphasic. The first phase involves testing basic science (e.g., an EST) in community applicable
ways such as through the use of effectiveness studies that include community mental health
patients and practitioners. The second phase involves researching the best ways to bring EBPs
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into the community (Brekke, Ell, & Palinkas, 2007). Together, these phases ensure that clinical
research can be brought into the community in the most effective ways possible, leading to the
greatest patient gains. However, despite, these efforts, clinicians continue to provide treatment
that is based on clinical acumen and what is familiar over scientific evidence (Lilienfeld et al.,
2013).
While phase one efforts have effectively translated basic science into clinical practice and
easy to use interventions, less attention has been paid to phase two efforts directed at
implementing these practice among community practitioners (Drolet & Lorenzi, 2011). For
example, phase two efforts typically only receive one percent of the funding that phase one
efforts receive despite their necessity (Tetroe et al., 2008). Phase two efforts are essential
because they take the burden of translating science into practice off clinicians who are already
skeptical, overwhelmed and unlikely to be motivated to implement a new practice without seeing
how it would work with their patients. Thus, without effective phase two efforts clinicians have
limited motivation to adopt EBPs while patient groups and families don’t have access to the
evidence-based care that they need (Eccles et al., 2009).
Intervention Model
According to the National Institute of Health ([NIH] 2014), a stage-based model of clinical
intervention development is thought to best develop and bring research into practice (Onken,
Carroll, Shoham, Cuthbert & Riddle, 2014). The model put forth by NIH starts with “Stage 0,”
which includes an understanding of the “basic science” needed behind the development of any
potentially meaningful intervention. The next stage, “Stage 1” includes the development of the
intervention or refinement of a standing intervention to prepare it for “Stage 2,” which includes
testing the efficacy of the intervention via a clinical trial. Once the intervention has passed the
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“efficacy” test, it needs to move on to “Stage 3” before it can be brought to the public. “Stage 3”
involves testing the efficacy of the intervention in the community via a well-controlled study in a
community clinic. This stage is followed by “Stage 4,” which includes testing the intervention
for effectiveness in the community in ways that emulate reality (i.e., without the strict controls of
an efficacy study). Once effectiveness is established, “Stage 5” involves finding ways to
implements and disseminate the practice into community settings.
NIH’s model cautions researchers and practitioners about skipping stages so as to ensure
the intervention will best be taken up and understood in the community. Specifically, the model
warns against moving from efficacy studies to dissemination and implementation before the
research is adequately translated into community practice and found to be effective. NIH posits
that “the work is not complete until an intervention reaches its highest level of potency and is
implementable with the maximum number of people in the population for which it was
developed” (Onken, et al., 2014 p. 27). Thus, highlighting the importance of translational
research in addition to the actual dissemination and implementation of an intervention into
community-based settings.
Dissemination and Implementation Research
While efforts to bring research into practice through dissemination and implementation
have received less attention than efforts to translate research into clinical practices, finding
effective ways to bring and maintain empirically supported interventions into community
settings has been gaining traction over the last ten years (e.g., Beidas et al; Proctor et al., 2009;
Proctor et al., 2011; Torrey et al., 2012). Efforts to effectively bring a new intervention to a
community involves the dissemination and implementation of a that intervention, with
dissemination and implementation often being talked about as one in the same. However,
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dissemination specifically refers to the communication of a new practice while implementation
involves the methods by which health care innovations most effectively take place and can be
sustained over time at policy, organizational and clinical levels (Proctor, Powell, & McMillen,
2013).
The term “implementation science,” which implies that it is the study of implementation,
typically also involves a dissemination component and is sometimes also referred to as
“dissemination & implementation (D&I) research” (Tabak, Khoong, Chambers & Brownson,
2012). Together, dissemination and implementation theories provide guidance to public health
advocates and government entities that wish to increase the use of EBPs among community
mental health providers through clinician adoption and implementation of these practices over
time. This area of research has become so important that some have proposed a ten year stop to
efficacy research in favor of determining the most effective and fastest ways to bring research to
practice (Kessler & Glasgow, 2011).
Dissemination and Implementation Theory
While early research on EBP implementation neglected theory in the selection of
dissemination and/or implementation strategies (Davier, Walker & Grimshaw, 2010; Eccles et
al., 2005; French et al., 2012; Michie et al.; 2005; Stelk, 2006; etc.), more recent studies have
both used and outlined some of the more basic theories behind EBP dissemination and
implementation (Dingfelder & Mandell, 2012; May, 2013; Tabak et al.,, 2012). Among
implementation scientists, efforts are being made to better incorporate and test organizational
and psychological theories that can help researchers select and test implementation strategies
(French et al., 2012). Theories behind D&I research help frame and bring context to
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dissemination and implementation strategies improving their likelihood to succeed (Tabak et al.,
2012).
Everett Rogers’ (2003) Diffusion of Innovations theory is one of the more popular theories
that is drawn upon in D&I research (Dingfelder & Mandell, 2012; Gotham, 2004; Stelk 2006;
Rohrbach et al., 1993). According to Rogers (2003), diffusion or dissemination is the process
used to communicate an innovative practice within a community over time. This process
involves “the innovation, communication channels, time and the social system” (Rogers, 2005 p.
33). In terms of EBP implementation, the social system would encompass a group or groups of
behavioral health providers, the EBP would be the innovation or new technology introduced to
providers, the communication channels would be the means by which and the individuals
involved in informing and educating those mental health providers of a selected EBP, and the
time involved and the rate at which an innovation is adopted would be measured by the number
of providers who adopt an EBP in a selected time period.
Building upon Rogers’ theory, Rohrbach (1993) and Dingfelder and Mandell (2012)
suggest that that the process of diffusion is continuous and typically includes four main stages:
dissemination, adoption, implementation and maintenance (Dingfelder & Mandell, 2012). The
dissemination stage involves the strategies needed to increase potential adopters’ awareness of
the innovation and obtain their buy in. The adoption stage is the point at which the system
commits to trying out the innovation. The implementation stage marks the time during which
individuals in the social system begin to use the innovation. And the maintenance stage begins
once the innovation moves from something new that is being tested out to becoming part of
community’s standard practice.
Each stage in the diffusion process is impacted by a variety of factors. The perception of
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the innovation accounts for the greatest variance in terms of whether an innovation will become
part of the system and stay a part of the system overtime (Rogers, 2003). Thus, the way in which
an innovation is packaged and sold is very important. According to Rogers (2003), and those
who have tested his theory, three attributes are of particular importance when trying to introduce
an innovation. These include the innovations’ complexity, compatibility and relative advantage
(Dingfelder & Mandell, 2012). Thus, the easier an innovation appears to be, its capacity to easily
fold into already existing practices and its benefits to the individual or community greatly
determine whether the innovation will be adopted.
While Rogers laid out his theory of diffusion over forty years ago, only recently have we
developed a better understanding of this and other theories as they relate to EBP implementation
(Proctor et al., 2009). As D&I research studies have gained traction so has our knowledge of
what is and isn’t effective in terms of changing clinician behaviors. For many years individuals
had little to go on beyond anecdotal information, case reports or controlled experiments with
little external validity (Glasgow et al. 2006). Yet, despite the lack of knowledge and the many
challenges that exist bringing EBPs into community mental health settings, federal, state and
local health departments have made EBP dissemination a priority. Despite evidence
demonstrating the importance of implementation science, federal and local efforts have primarily
focused on dissemination and the development of specialty training initiatives as opposed to
ensuring the implementation of evidence-based practices in community mental health settings
(Herschell et al., 2010; Barlow et al., 2013). While the desire to increase the use of EBPs
through direct training programs is understandable, focus on training alone may have been
premature.
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Clinical Training
Research now shows that training alone is not an effective means by which behavioral
change takes place (Beidas, et al. 2012; Brunette et al., 2008; Joyce & Showers, 2002; Whitley,
Gingerich, Lutz, & Mueser, 2009). Despite well-intentioned efforts, these finding may help
explain why many clinicians still do not provide evidence-based support. Although training can
increase clinicians’ knowledge about an evidence-based practice, it has not been shown to lead to
clinicians incorporating what they have learned into their day-to-day work (e.g., Beidas et al.,
2012; Davis et al. 1999; Walters et al. 2005). In a study by Davis et al. (1999), that evaluated
continuing medical education, Davis and colleagues found that didactic education sessions did
not lead to behavior change and limited knowledge transfer, while interactive training, provided
greater knowledge transfer but with limited overall gains. This trend is also true for behavioral
health settings, even when training is coupled with a contractual mandate to provide EBPs,
clinician behavior doesn’t change (Lopez, Osterberg, Jensen-Doss, & Rae, 2011).
Most D&I researchers agree that implementation of an evidence based practice requires a
variety of components (Torrey, Tepper and Greenwold et al., 2011; Sylavian & Lamothe, 2013).
Some factors that have been shown to increase the likelihood that an evidence based practice will
be implemented include strong “change” leaders who can manage and oversee implementation
efforts at the program level; staff motivation and interest in the treatment modality; staff
perception that change is needed; financial and administrative support; oversight that requires
providers to track and report organizational and client level outcomes; continuous workforce
development, which includes but is not limited to staff training in conjunction with strong
clinical supervision and expert consultation; favorable attitudes toward EBPs; and management
of staff turnover (Aarons et al., 2012; McGovern, Lambert-Harris, McHugo, Giard & Mangrum,
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2010; Torrey et al., 2011; Sylvain & Lamothe, 2013). Thus, training efforts alone can no longer
be used to ensure an EBP will become part of one’s clinical practice.
Expert Consultation/Supervision and Implementation Research
While efforts have been made to include many of the aforementioned implementation
variables within single studies – some of these variables are easier to control than others. For an
outside entity (e.g., government) mandating training or beginning to introduce an EBP, expert
consultation and funding may be easier variables to control than staff motivation, internal
supervision or internal oversight because expert consultation and funding can be controlled
externally. Expert consultation is particularly easy for those implementing training to include in
training plans granted funding is accessible. Expert consultation is typically provided by the
individual or affiliated individuals conducting a training and can be sold as part of the full
training package. In particular, if expert consultation involves clinical supervisors it has the
benefit of helping to ensure clinical supervision on the training material is built into a program’s
internal structure.
Since clinical supervision is commonly assumed to be part of standard practice, one may
assume that in-house clinical supervision would take place post-training to promote the use of
the training modality taught. However, post-training supervision has traditionally been
unstandardized and left to mid-level managers who themselves are not experts and at times have
not been trained on the EBP that was taught. As such, most clinicians do not have access to
regular internal post-training supervision of what they have learned (Milne, 2010). Expert
supervision or consultation provided by trainers or treatment developers, on the other hand, is
usually standardized and ensures someone familiar with the specific treatment modality provides
the supervision. This familiarity combined with structured supervision increases the likelihood
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that supervision will lead to treatment implementation or ensure that clinical supervisors are
equipped to supervise their staff (Bearman et al., 2013; Beidas et al., 2012; Milne, 2010).
Despite growing evidence that expert consultation and clinical supervision lead to
increased treatment implementation, little research has been done pertaining to this type of
supervision outside of highly controlled clinical studies with volunteer subjects or involving
clinicians providing treatment as part of a separate evidence based treatment models
(Sholomskas et al., 2005) and results have even been mixed. In a recent study by Torrey, Bond,
McHugo and Swain (2012), an inverse relationship between supervision and implementation was
found. Furthermore, research on implementation factors among evidence-based treatments for
special populations is even less prevalent and little research has been done to determine the
effects of training and supervision on clinical outcomes among individuals with complex cooccurring disorders (Barlow et al., 2013; Proctor et al., 2011; Torrey et al., 2012). Millions of
dollars are spent every year to train new staff and increase competence and therefore determining
ways to support and sustain these initiatives is needed to avoid wasting money and to ensure that
individuals in the community receive the care they need.
Proctor and colleagues (2011) suggested that more research is needed in this area to
determine the extent to which supervision and other implementation supports benefit clinical
practice. Specifically, few studies have measured client level outcomes as they relate to
supervision within treatment implementation studies (Schoenwald, Mehta, Frazier & Shernoff,
2013). Research does show supervision is particularly meaningful within the context of agency
buy-in and workflow changes (Brunette et al., 2008; Rapp, Goscha, & Carlson, 2010). And it
seems as though the key component by which supervision works is how it encourages increased
clinical practice in the treatment modality taught. Thus, it is the increased attention paid to staff
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and continued focus on the learned treatments by agency leadership and supervisors themselves
that promotes the implementation of a model after training (Whitely et al., 2009).
Supervision provided by trainers or other experts is relatively easy for agencies funding
trainings to provide and has been shown to increase the likelihood a treatment will be
implemented post-training (Beidas et al., 2012; Beidas & Kendall, 2010; & Sholomskas et al.,
2005; Miller et al., 2004). One way that such supervision is provided involves the use of
consultation calls, and research looking at this method of consultation has found promising
results (Bearman et al., 2013; Beidas et al., 2012). However, these tools have primarily been
evaluated among youth treatment providers and have not been evaluated among ACT Teams,
which are constantly on the go and already work within an evidence based frame.
SMI, PTSD, SUD and the rationale for Evidence-Based Practices
While there are many challenges and much is still unknown in terms of implementing
evidence based practices in the community, for individuals with complex co-occurring needs,
evidence-based care is extremely important (e.g., Fuller, 2010; McGovern et al., 2011; Mueser,
Noordsy, Drake, & Fox, 2003; Mueser, et al., 2008). For individuals with SMI, who have cooccurring PTSD, and SUD this is especially true because rates of trauma exposure among
individuals with SMI are up to twelve times higher than the general population, PTSD is under
diagnosed among people with SMI, clinicians rarely provide PTSD treatment or integrated SUD
treatment to individuals with SMI and most importantly, untreated PTSD and SUD increase the
burden of illness among individuals with SMI, (Fuller, 2010; Mueser et al., 2008; Mueser et al.,
2002; Mueser et al., 1998; Read, Hammersley, & Rudegeair, 2007; Switzer et al., 1999; Subica,
Claypoole & Wylie, 2012; & O'Hare, Shen, & Sherrer, 2012).
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Rates of trauma exposure and PTSD are much higher among individuals with SMI than
in the general population (Mueser et al., 2008; O'Hare, Shen, & Sherrer, 2012). Being exposed to
trauma in childhood nearly triples one’s chance of developing a psychotic disorder (Varese et al.,
2012). Yet, PTSD and trauma screening does not routinely take place in community mental
health settings, where most individuals with SMI receive treatment, despite the availability of
reliable and valid PTSD screening and assessment tools for individuals with SMI (Grubaugh,
Elhai, Cusack, Well & Frueh, 2007). In one study conducted by Mueser and colleagues (1998)
where forty-three percent of individuals with SMI receiving community mental health services
met criteria for PTSD, only two percent of individuals had a PTSD diagnosis documented in
their charts.
For individuals with SMI, many of whom may display psychotic symptoms or have
major life stressors (e.g., homelessness, recurrent hospitalizations, medical needs, etc.), clinicians
often feel the need to address those more obvious needs first and throughout (Freuh et al., 2010).
Thus, clinicians become blinded to the possibility of a PTSD diagnosis and ignore the need for
PTSD treatment. This is further complicated by the fact that most clinicians in community
mental health setting have not been trained to recognize, or detect trauma (Freuh et al., 2001).
This is unfortunate, considering that many of the overt symptoms and life stressors that clinicians
observe are likely related to untreated PTSD symptoms, which could be easily detected with the
use of a simple screening tool (Cusack, Frueh & Brady, 2004; & Mueser, Rosenberg, Goodman
& Trumbetta, 2002).
Even if routine trauma screening and assessments take place, the behavioral health
workforce is not equipped to provide evidence based trauma treatments due to lack of training
and misconceptions about treating trauma among individuals with SMI (Frueh 2001; Freuh et al.,
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2010). Trauma treatments are not readily available in community mental health settings in part
because of under diagnoses but also due to genuine fears that treating PTSD among individuals
with SMI will lead to increased psychiatric symptoms despite evidence that proves otherwise
(Mueser et al., 2008). This is further complicated and substantiated since most community
mental health clinicians are trained to provide case management and respond to the core
disorders associated with SMI (e.g., major depression, bipolar disorder, schizophrenia, etc.) and
not trauma (Frueh 2001; Freuh et al., 2010). Many of these providers have traditionally seen their
patients as fragile and prefer to provide medication management services to address overt
symptoms over psychotherapy (Cusack, et al., 2007). Similarly, clinicians have not and still do
not always think it makes sense or feel comfortable providing treatment to individuals with
substance use needs for similar reasons despite evidence that individuals with COD respond best
to treatments that integrate mental health and substance use needs (Mueser et al., 2003).
Despite concerns of clinicians and inadequate training, lack of PTSD treatment is an issue
because untreated PTSD among individuals with SMI leads to increased substance use,
psychiatric symptoms, physical health problems, difficulty functioning; and psychiatric
hospitalizations (Mueser et al., 2002; Mueser et al., 2004; Switzer et al., 1999; & Subica,
Claypoole & Wylie, 2012). Individuals with trauma histories not only are prone to increased
psychiatric symptoms and hospitalizations, but are more likely to have hypertentsion, obesity,
and cardiovascular disease (McFarlane, 2010). Thus, exacerbating the individual and societal
burden of illness. Trauma exposure, and PTSD, in particular, is associated with some of the
greatest amounts of healthcare use and costs when compared to the general population
(Greenberg et al., 1999; Hidalgo & Davidson, 2000; Kessler, 2000). Thus, leaving PTSD
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untreated not only negatively impacts care and the individual receiving treatment but the health
care system at large (Freuh et al., 2010).
Evidence Based Treatment for PTSD
Despite a lack of PTSD treatment available in the community, several treatment
approaches have been shown to effectively treat PTSD. The American Psychiatric Association
identifies exposure-based therapies, cognitive behavioral and cognitive restructuring therapies,
Eye Movement Desensitization and Reprocessing (EMDR) and medication in their treatment
guidelines for PTSD (APA, 2004). Of these treatments, exposure-based therapies, which
gradually re-introduce the individual to his or her past trauma in a safe environment, have the
strongest research base (Bomyea & Lang, 2012; Rothbaum, Meadows, Resick & Foy, 2000).
However, despite, stronger evidence for treatments with exposure components, exposure
therapies have not traditionally been accepted among clinicians or tested rigorously for certain
patient groups, including individuals with psychosis, extreme emotions, co-occurring conditions
and/or active substance use disorders (van Minnen, A., Harned, Zoellner, & Mills, 2012; & Foa,
2007).
While the research base is strongest for exposure based treatments and recent studies
have started to show promise using exposure-based treatments for individuals with psychosis
(Freuh et al., 2009; van den Berg & van der Gaag, 2012; de Bont, van Minnen & de Jongh,
2013), at the time of this study there had been no controlled studies for this population to show
whether or not it is safe and/or effective (Mabey & Servellen, 2014). Furthermore, for
individuals with psychosis and/or other serious mental health conditions, facing feared situations
or memories has been thought to be too stressful for both clinicians and patients due to symptom
exacerbation (Mueser et al. 2008). However, since this study took place, one study has found
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prolonged exposure therapy safe and effective for this population (van den Berg et al., 2015).
Nonetheless, despite these promising findings, clinicians are hesitant to treat trauma among
individuals with SMI in general, exposure based treatments may be extremely difficult to sell
clinicians to practice. Similarly, for individuals with substance use disorders there have been
concerns about the use of exposure based treatments for this population in increasing substance
use (Hien et al., 2004; McGovern et al., 2009; Foa 2007; etc) and evidence of high dropout rates
(Brady, Dansky, Back, Foa & Carroll, 2001). A few pilot studies and one controlled trial have
shown promising results in terms of demonstrating patient safety, but treatment outcomes have
not consistently demonstrated patient benefits across studies (Brady, Dansky, Back, Foa, &
Carroll, 2001; Foa et al., 2013; Najavits, & Johnson, 2014; Mills et al., 2012).
While exposure based therapies have the strongest research base, implementing such
treatments in community mental health settings is not yet indicated for individuals with SMI
and/or SUD. There is, however, evidence that non-exposure based Cognitive Behavioral Therapy
(CBT) is equally as effective as some exposure-based treatments (Monson, Rodriguez & Warner,
2005). Furthermore, CBT for PTSD developed by Mueser and colleagues (2008) was developed
specifically for individuals with SMI and has been found to be safe, effective and better than
treatment as usual for individuals with SMI and PTSD (Mueser et al., 2008; & Mueser et al.,
2015)). CBT for PTSD focuses on the here and now by directly targeting PTSD symptoms
through relaxation skill training and cognitive restructuring techniques that teach patients how to
evaluate their thoughts to change their feelings and corresponding reactions to situations.
Integrated CBT for PTSD and Addiction (ICBT)
ICBT (McGovern et al., 2011) uses the basic components that make up CBT for PTSD
(Mueser et al., 2008) but differs in that it includes a component that addresses harmful substance
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use. Like CBT for PTSD, ICBT is comprised by a variety of EBPs including motivational
interviewing, mindful relaxation, psycho-education and cognitive restructuring. ICBT has found
to be safe and effective among individuals in substance use treatment with a variety of severe cooccurring mental health needs and is easy for clinicians and patients to use (McGovern et al.,
2011). Unlike the original CBT for PTSD, ICBT has the benefit of addressing harmful substance
use, which is exacerbated by and extremely common among individuals with SMI and PTSD
(Subica et al., 2012).
SMI, PTSD and SUD and Assertive Community Treatment (ACT)
ACT is a community treatment model made up of a team of social workers, psychiatrists,
nurses, caseworkers and peers who provide treatment to patients in their homes on a two time
weekly basis with a minimum of six visits per month for fifteen to forty five minutes at a time.
The original ACT model was developed in the 1970s and originally called Training in
Community Living (Stein & Test, 1980). In the original model and subsequently after being
named ACT, the point of this form of treatment was to act as a hospital without walls, keeping
individuals who were frequent users of psychiatric inpatient treatment in the community to
reduce cost and promote community reintegration (Bond et al., 2001). ACT has an extensive
evidence-base demonstrating that it helps individuals stay out of the hospital, leads to stable
housing and reduces psychiatric symptoms and improves life quality (Bond et al., 2001).
ACT Teams are comprised by nurses, social workers, psychiatrists and peer counselors.
Each team serves sixty-eight clients. Teams share caseloads, and as such all Team members treat
all sixty-eight clients. ACT is indicated and available to individuals with SMI who have
previously had difficulty adhering to traditional treatment. To meet ACT eligibility criteria, the
individual seeking or referred to ACT services needs to have a SMI and demonstrate a history of
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treatment non-adherence and recent psychiatric hospitalizations (New York State Office of
Mental Health, 2013). As such, PTSD and substance use disorder rates are likely to be higher
among ACT patients than for individuals in traditional community mental health programs since
research indicates that outcomes and treatment adherence are typically worse for individuals with
co-occurring PTSD and SUD (Fuller, 2010; McGovern et al., 2011; Mueser et al., 2008).
However, prior to this study, ACT Teams had not previously received any type of trauma
training.
Current Study
As part of a larger initiative focused on improving access to best practices for COD among
recipients of New York City Department of Health and Mental Hygiene (DOHMH) contracted
mental health programs, approximately 306 ACT Team workers across 43 ACT Teams were
trained to use ICBT over a three-week period between April and May of 2013. To support the
implementation of ICBT, follow-up supervision and consultation by experts was offered to all
ACT Teams post-training. The initiative manipulated the amount of supervision and consultation
received by teams in a quasi-experimental design. Specifically, Team supervisors were able to
volunteer themselves or staff with supervisory capacity to participate in receiving on-going
supervision and training support after the initial round of follow-up support and supervision was
provided.
Hypotheses
Based on the literature, a framework for training and supervising clinicians post-training in
an EBP was developed. As outlined above, trainings alone don’t work and thus by including
supervision and consultation into the training plan, provider implementation of ICBT was
expected to be higher and patient outcomes were expected to be better when more supervision

21

was received. Specifically, it was hypothesized that ACT Teams that receive increased
supervision and consultation would show greater use of ICBT and better patient outcomes than
Teams with less supervision and consultation. It was hypothesized that ACT Teams that received
additional support would be encouraged to provide ICBT more by being more comfortable
providing it and as a result of their on-going exposure to it. Thus, those ACT Teams were
expected to provide more adherent ICBT sessions than those Teams that received the standard
training and supervision. With greater sessions that are more adherent, patient outcomes were
also expected to be better in the group with more support.
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Chapter 3: Research Method
Method
Participants
Forty-three New York City ACT Teams comprised by 350 clinical staff members were
offered ICBT Training and post-training supervision as part of a DOHMH initiative to promote
the use of trauma informed practices to individuals with SMI and CoD in NYC.
Of the 350 clinical staff members offered the training, 306 individuals across all fortyfour teams accepted the training offer and were trained between April and May of 2013. The 306
clinical staff members included individuals from high school graduates to Doctoral level
educational backgrounds. No data are available on the demographic makeup of these providers.
Approximately 157 clients across the 43 teams were identified with PTSD, SUD and SMI
(See Figure 1 below for client characteristics from original ACT consumers screened). These 157
individuals were tracked between May 2013 and April 2014 on a monthly basis to determine the
number of ICBT sessions received, substance use severity and hospitalization utilization. In
order to keep consumer data confidential and to decrease the data collection burden, no
demographic data was collected for the individuals receiving ICBT.
Study Design
This was a quasi-experimental design consisting of two groups, one group that received a
standard Integrative CBT (ICBT) Training for PTSD and addiction with supervision versus
another group that received the same ICBT training plus additional supervision and consultation
(i.e., the Master Level Training). The two groups were formed on a volunteer basis whereby
teams that received the Master Level Training volunteered for this additional support once the
Master Training was offered. Teams in both groups reported monthly data on treatment
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implementation and clinical outcomes (substance use, PTSD, Stage of Change, and psychiatric
emergencies). All data were collected and analyzed at baseline and 3month, 6-month, 9-month
and 12-month follow-up intervals.
Design Specifics
Forty-three New York City ACT Team members were offered ICBT Training and posttraining supervision as part of a DOHMH initiative to promote the use of trauma informed
practices to individuals with SMI and COD. Prior to the training all Team supervisors (n=43)
were instructed to collect data on all enrolled consumers (n=2,924). Team supervisors met
monthly at DOHMH as part of a standard ongoing ACT Team meeting. Teams were informed of
the data collection procedures one month prior to the first training date at one of their monthly
meetings. Supervisors were sent a data collection form along with a PTSD (PC-PTSD) and a
SUD (CAGE-AID) screening tool with instructions. Supervisors were instructed to have their
clinical staff screen all consumers prior to the first day of training in order to identify clients with
both PTSD and SUD for the ICBT treatment. Of the possible 2,924 ACT clients, 2,082
consumers were screened for PTSD and SUD (See Figure 1, for breakdown of client clinical
characteristics).
Figure 1. Pre-Study PTSD and Substance Use Screening Results

23% SUD
Only (N=479)
63%
No PTSD and
No SUD
(N=1312)

8% SUD and
PTSD
(N=157)
6% PTSD Only
(N=134)
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Clinical staff members were trained with their ACT Teams in groups of twenty-five to
forty-four participants across three 1-day intensive ICBT Trainings to review the ICBT manual
and learn how to implement the model. Each Team received two manuals and was charged to
implement the model across those clients who met the criteria for PTSD and SUD based on the
initial screening data. Teams were instructed to collect monthly data on those consumers who
screened positive for both PTSD and SUD. Teams were instructed to use their first ICBT visit to
fully assess those clients who screened positive for PTSD and SUD for PTSD using the PCL as
the baseline measure for PTSD symptoms. Teams were also instructed to assess their clients
SUD severity using the AUS (Alcohol Use Scale) and DUS (Drug Use Scale) during the first
ICBT visit. During the initial training, the DOHMH training coordinator thoroughly explained
the monthly data collection procedures and forms, which included space to report AUS, DUS
and PCL scores. In addition, providers were asked to report on their clients’ Stage of Change and
whether the client went to a psychiatric emergency room during the reporting month and whether
the client was admitted to the hospital for psychiatric reasons that month. Finally, clinicians were
asked to report the number of ICBT and non-ICBT sessions conducted for the reporting month to
determine the degree to which providers were implementing ICBT. As part of the 1-day training,
providers were trained on the use of the above mentioned outcome measures and assessment
tools. Clinical outcome data and number of ICBT sessions were collected monthly in a data file
created by the Training Coordinator, with the first data submission that was due June 7, 2013.
The data collection forms were used to track client and implementation outcomes over a 12month period.
Each team was contacted by the Training Coordinator to set-up 2 follow-up 90-minute
supervisory phone calls as part of the standard ICBT training (i.e., what everyone receives). The
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phone calls were provided individually to each team (i.e., there will be 86 phone calls across 43
teams) and led by either the trainer or the treatment developer. The phone calls reviewed ICBT
cases with the teams and provided supervision and technical assistance to ACT Team members.
Once all providers participated in their first of two follow-up phone calls, the Training
Coordinator offered ACT Team Supervisors and staff with supervisory roles the opportunity to
participate in a “Master Training” on a volunteer basis. The Master Training involved three
additional supervisory phone calls led by the ICBT trainer and treatment developer. The Master
Training involved 15 ACT Teams, with one person from each team on the call. The phone calls
discussed ways in which to further support staff needs in terms of implementing ICBT in
addition to providing technical assistance related to specific ICBT cases. Supervisors were going
to be the only Team members offered the training but due to low response from supervisors and
high response from clinical staff a provision was made to allow any staff member to participate
as long as they had the opportunity to provide some level of ICBT supervision to their fellow
Team members. This was done in order to promote clinical ICBT supervision across Teams with
Master Trainers.
Teams were required to collect and report on monthly client and implementation level
data for 12-months. Teams were then compared on the outcome measures by training status (i.e.,
whether the Team had a supervisor receive the Master Training) at baseline, 3-month, 6-month,
9-month and the end of the 12-month intervals. The number of ICBT sessions in relation
treatment outcomes was also be evaluated to determine if the number of ICBT sessions improved
clinical outcomes.
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Measures
For the initial PTSD screening, the PC-PTSD (Primary Care PTSD Scale) was used.
The PC-PTSD is a 4-item scale originally developed for primary care sites and other medical
settings. The screen asks 4 questions, which relate to the DSM-IV TR (APA, 2000) criteria of
general distress, avoidance, hyper-arousal and re-experiencing symptoms of PTSD. Each
questions is answered with a “yes” or a “no” and scores range from 0-4, with a score of 3 or
above indicating probable PTSD. The PC-PTSD has excellent inter-rater reliability and good test
retest reliability. In addition the measure has good diagnostic efficiency in primary care settings
with a score of three yielding specificity of .87 and sensitivity of .78 and (Prins et al., 2003).
Though this tool was meant to be used in a primary care setting, it was selected because of its
ease of use and short length.
For the initial SUD screening, the CAGE-AID (Cut down, Annoyed, Guilty, Eye
opener – Adapted to include Drugs) was used. The CAGE-AID was developed for the World
Health Organization for substance use detection in medical settings. The original measure, the
CAGE, only assessed for Alcohol but an adapted version of the tool, CAGE-AID, was created to
include drugs. The CAGE-AID is a 4-item that asks questions, which relate to the DSM-IV TR
(APA, 2000) criteria of Substance Abuse and Dependence. The CAGE-AID evaluates alcohol
and/or drug use. Each questions is answered with a “yes” or a “no” and scores range from 0-4,
with a score of 1 or above indicating possible SUD. The CAGE has good reliability and validity
and has been validated in groups of individuals with SMI (Center for Substance Abuse
Treatment, 2005). The CAGE-AID was selected because of its ease of use, short length and use
among individuals with SMI.

27

For individuals who screened positive for PTSD and SUD, PTSD symptoms were then
assessed and tracked using the PCL (PTSD Check List). The PCL assess all seventeen PTSD
symptoms listed in the DSM-IV TR using 17 corresponding self-report items. Each item is rated
from 0-5 on symptom severity with “0” being “not at all” and “5” being “extremely.” Scores can
range from 0 to 68. Scores 44 or higher indicate probable PTSD. The PCL has excellent testretest reliability, high internal consistency and correlates highly with other measures of PTSD
(Weathers, Litz, Herman, Huska, & Keane, 1993). The PCL has been used reliably across groups
with both SMI and SUD (McGovern et al., 2011). The PCL was selected because of its ease of
use, relatively short length and use among individuals with SMI.
For individuals who screened positive for PTSD and SUD, substance use symptoms were
assessed and tracked using the AUS (Alcohol Use Scale) and the DUS (Drug Use Scale). The
AUS and DUS are very simple, yet reliable measures of substance use, which use a 5-point
clinician rated scale (from “no problem” to “extremely severe”) an individual’s use of alcohol
(i.e., on the AUS) and/or drug (i.e., on the DUS), which correspond to DSM-IV TR criteria for
substance abuse and dependence. The AUS and DUS have high sensitivity and specificity, and
good inter-rater and test re-test reliability within groups of individuals with and without SMI.
(Drake et al., 1998). The AUS and DUS were selected because they are easy for clinicians to use
and because they have previously been used in groups of individuals with SMI.
Interventions
Integrated Cognitive Behavioral Therapy (ICBT) is a manualized treatment for PTSD
and SUD developed at Dartmouth by Mark McGovern, PhD and colleagues (2010). ICBT was
developed as an adaption of CBT for PTSD for individuals with SMI developed by Kim Mueser
and colleagues at Dartmouth (2008). ICBT was adapted to include addiction treatment within the
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context of PTSD and SMI. McGovern and colleagues’ (2010) ICBT manual outlines a skillsbased approach to treating PTSD with CBT. This model explains CBT for PTSD in a step-bystep manner across 8 modules, to be conducted over 12-16 weekly sessions. The clinician
manual includes a client workbook that provides the client with handouts and homework
assignments to reinforce ICBT modules.
Module 1 (Introduction to Treatment) outlines the therapy approach, goals and
mutual expectations. In Module 2 (Crisis & Relapse prevention plan), the
clinician and patient review early warning signs, coping strategies and social
supports to manage substance use and/or relapse. Module 3 (Breathing
Retraining) teaches the patient an anxiety reduction skill. Module 4 (PTSD:
Primary symptoms) introduces the three PTSD criterion symptoms (Reexperiencing, Avoidance, Hyper-arousal) and provides patient education and
normalization. Module 5 (PTSD: Associated Symptoms) identifies common
negative emotions and affects associated with PTSD (a. Fear and anxiety; b.
Sadness and depression; c. Guilt and shame; and d. Anger) as well as the
interpersonal consequences of PTSD. A significant portion of this module is
devoted to examining the interplay between PTSD symptoms and substance use.
The cognitive behavioral technique of cognitive restructuring is the focus of
Module 6 (Cognitive Restructuring Part I) and Module 7 (Cognitive Restructuring
Part II). Module 6 focuses on the basic framework of identifying stressful
activating

situations,

beliefs/thoughts

and

consequences

(emotional

or

behavioral). Module 7 builds upon this framework and skill development by
including steps on disputing the belief (incorporating common styles of thinking
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handouts) and generating alternative emotions or behaviors. The final module,
Module 8 (Generalization training) is designed to bring closure to the therapy
relationship, consolidate a plan for continued application of the skills, and
consider further treatment options. (McGovern et al., 2011, p. 211-212).
Master ICBT Training (Increased Supervision) was used as the main intervention to
determine between group differences on clinical outcomes and ICBT implementation.
The Master Level training involved additional support and training provided to
approximately 22 team supervisors via phone consultation by the treatment developer
(Mark McGovern) and/or the ICBT trainer. During the Master phone calls, the
consultation provided included discussions on the ways in which supervisors could
further support staff needs in terms of implementing ICBT in addition to providing
technical assistance related to specific ICBT cases.
Data Analysis
Of the 41 ACT Teams trained in ICBT, 28 agreed to participate in the study.
However, due to unreliability of the data from four teams, these data sets were removed
from the analysis. Therefore, we analyzed data from 12 Master and 11 Non-Master
programs. 107 patients were represented across the 23 teams with 56 patients receiving
services on Master Teams and 51 patients receiving services from Non-Master Teams.
Data were analyzed using SPSS (17) (SPSS, 2008). Due to the data being non-parametric
and because our small sample size was too small to meet the necessary power for statistical tests
of significance, only descriptive statistics and effect sizes were used to analyze the data.
Descriptive statistics were analyzed to determine the average number of ICBT sessions provided
by Teams with without Master Level Clinicians during each month of the project. Effect sizes
30

evaluated the strength of the differences between Master and Non-Master Team outcomes.
Furthermore, we used SPSS to generate treatment outcome data for each of these groups, which
included differences in AUS, DUS and PCL scores by number of ICBT sessions received.
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Chapter 4: Results
Results
Initial Training Information
Each ACT Team participated in an initial ICBT training on 1 day between April and May
of 2013. 9 out of 12 Master teams received their initial 1-day ICBT training at the end of April
and 4 out of the 12 Master teams received their initial 1-day ICBT training early in May. For
Non-Master Teams, 4 of the 11 teams received their training at the end of April and 7 of 11
teams received their training in early May. As a way to capture all participant data during the
time the ACT Teams received their initial ICBT training, the first reporting period during which
ACT Teams reported ICBT data spanned five weeks (April 24, 2013 to May 31, 2014). All other
reporting periods were 1 month long. As such, the first data period carried a bias in favor of
teams that participated in their one day training earlier in the reporting period since there was
more time for teams trained earlier to use their ICBT skills.
During the first reporting period, 1 of the Master Teams received their initial ICBT
supervisory call while none of the Non-Master Teams received an initial supervisory call. During
the second reporting period, 4 Master and 3 Non-Master Teams received their initial ICBT calls.
During the 3rd reporting period, 7 Master and 7 Non-Master Teams received their first
supervisory call. During the fourth reporting period 3 Master Teams received their second
supervisory call while 1 Non-Master Team took part in its first call. By the fifth reporting period,
4 Master and 4 Non-Master Teams took part in their second supervisory calls. During the 6th
reporting period 4 Master and 6 Non-Master teams participated in their second supervisory call.
During the 7th reporting period 1 Master and 1 Non-Master Team took part in their second
supervisory call. By the 8th reporting period all teams had participated in their two supervisory
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calls. During the 8th reporting period the first two sets of Master calls took place with all Master
Teams attending at least one Master Call. See Figure 1 for visual representation of when
supervisory calls took place. 20 Master Teams participated in the first 2 Master Calls with 8
teams participating in both calls, one team missing 2 calls and 2 teams missing 1 call. During
period 9 the last Master call took place with 11 teams participating and 1 team missing the call.
ACT Team Characteristics
The composition of all ACT Teams across NYC is required to meet certain State
requirements. This composition, thus ensures, similar levels of staff education and training
across all teams. The main difference between ACT Teams and other outpatient clinical care
services is that ACT Teams have a higher staff to consumer ratio, due to the severity of mental
health symptoms required to receive ACT services. All ACT Teams are required to have at least
1 clinical staff member for every 9 consumers and each position on the team must meet specific
education and experience requirements. Therefore, teams have very similar characteristics in
terms of staff level of experience and education, in addition to the number of staff members on
each team. Similarly, each team is comprised by 68 consumers, with only very rare occasions
that a team is not at their full consumer capacity. Upon further analysis, there were no noticeable
differences in staffing pattern between Master and Non-Master teams. Demographic data were
requested from teams but due to a less than 50% response rate, this data have been excluded.
However, when looking at Master Teams alone, and more specifically the individuals who
participated in the calls, 9 of the 12 Master clinicians were early career clinicians while, 3 of the
12 clinicians were Team Leaders (individuals with more experience in leadership positions).
Anecdotally, two of the most active ICBT Master clinicians, left their ACT Teams for better
career opportunities toward the end of the study.
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There was one main difference between Master and Non-Master Teams in terms of
patient characteristics that we were able to find. Specifically, Master Teams had fewer Assisted
Outpatient (AOT) consumers on their entire caseload compared to Non-Master Teams during the
month prior to teams signing up for the Master training. AOT consumers are mandated to
treatment by the court and ACT teams are thus responsible for providing those individuals with
more in-depth care and submitting weekly reports to the City of New York – thus leading to an
increased workload. Furthermore, individuals on AOT are thought to have more severe mental
health and substance use needs, thus giving the appearance that they require more attention. For
Master Teams, 19.2% (N=10) of all of the consumers in the data reported had an AOT court
order, while 25% (N=13) of all Non-Master Team consumers reported in the data had an AOT
court order (See Figure 2 below).

Figure 2. Percent AOT Clients on Master Versus Non-Master Status Teams
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Initial Consumer Characteristics
Patient AUS, DUS and Stage of Change scores were collected each month by a team
assigned ACT Team member. AUS and DUS scores ranged from 1 to 5 with 1=Abstinence;
2=Use without Impairment; 3= Abuse; 4= Dependence and 5 = Severe Dependence. Stage of
Change Scores also ranged from 1 to 5 with 1= Pre-contemplation; 2 = Contemplation; 3 =
Preparation; 4 = Action; and 5 = Maintenance. See Table 1 for a display of the following initial
consumer characteristics.
Table 1 Initial Consumer Characteristics by Master Team
Master
Status

Average AUS
Score

Average DUS
Score

Average Stage of
Change

% with at
least 1
ER Visit

% with at
least 1
Admission

Master
Teams
(N=12)

1.9
(SD=.932)

2.51
(SD= 1.45)

2.59
(SD= 1.44)

11%
(SD=.32)

11%
(SD= .32)

Non-Master
Teams
(N=11)

2.4
(SD=1.27)

2.19 (SD= 1.31)

2.35
(SD=1.45)

20%
(SD=.4)

15%
(SD=.36)

The average AUS Score for consumers on Master Teams was 1.90 (SD=.932) during the
first reporting period while the average AUS score for Non-Master Teams was 2.4 (SD= 1.27).
The average DUS score for Master Teams was 2.51 (SD= 1.45) and for Non-Master teams the
average DUS score was 2.19 (SD= 1.31). The average Stage of Change score was 2.59 (SD=
1.44) for Master Teams and 2.35 (SD=1.45) for Non-Master Teams.
During the first reporting period and throughout teams reported on whether or not
consumers went to the ER or the hospital for psychiatric reasons during each reporting period.
During the first reporting period, an average of .11 (SD= .32) consumers went to the hospital on
at least one occasion from Master Teams and an average of .15 (SD=.36) consumers went to the
hospital on at least one occasion on Non-Master Teams. For Master Teams an average of .11
(SD=.32) individuals went to the ER at least one time and an average of .2 (SD=.4) individuals
went to the ER at least one time on Non-Master Teams during the first reporting period.
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ICBT Session Data
Overall, Master Teams provided an average of 55.58 ICBT sessions (SD=26.19) during
the 12 months of the study while Non-Master Teams provided an average of 30.81 ICBT
sessions (SD=17.59). A summary of the average number of ICBT sessions across each of the 12
months of the study for Master and Non-Master Teams is in Table 2 below and a breakdown
comparing Master and Non-Master Teams on ICBT sessions provided is in Figure 3 below.
Table 2 ICBT Session Data (standard deviation in parenthesis)
Reporting
Month

Avg ICBT
Sessions
Master Teams
(SD)

Number of
Mater Teams
Participating
in Supervisory
Calls

Month 1
Month 2

3.00 (2.45)
3.50 (2.15)

1
4

1.36 (1.50)
3.36 (2.69)

0
3

1.64
.14

Month 3

5.25 (2.67)

7

2.91 (2.34)

7

2.34

Month 4

4.33 (3.03)

3

2.27 (2.76)

1

2.06

Month 5

4.92 (1.73)

4

2.45 (2.34)

4

2.47

Month 6

5.58 (4.25)

4

3.18 (2.79)

6

2.4

Month 7

5.5 (4.76)

1

3.55 (3.21)

1

1.95

Month 8*

5.92 (4.99)

23

2.91 (3.27)

0

3.01

Month 9*

4.92 (3.55)

13

2.64 (2.66)

0

2.28

Month 10

4.67 (3.14)

0

2.27 (1.68)

0

2.4

Month 11

4.00 (3.02)

0

1.73(1.56)

0

2.27

Month 12

3.92 (2.68)

0

2.18 (1.88)

0

1.74

55.58 (26.19)

---

30.18 (27.70)

---

24.7

Total

Avg ICBT
Sessions for
Non-Master
Teams (SD)

*Months during which Master calls took place
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Number of NonMaster Teams
Participating in
Supervisory Calls

Avg
Difference
in ICBT
Sessions

Figure 3. Master vs. Non-Master Teams on ICBT Session Frequency
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The mean difference between the average number of ICBT sessions provided by Master
and Non-Master Teams was found to be large (Cohen’s d=1.11 r=.49). During the first reporting
period, Master Teams provided an average of 3 (SD=2.45) ICBT sessions per team while NonMaster Teams provided an average of 1.36 (SD=1.5) ICBT sessions per team demonstrating a
large effect size (Cohen’s d=.81; r=.37). During the first month, Master Teams provided almost
double the average number of ICBT sessions (M=3) than non-Master Teams (M= 1.5). However
this number must be interpreted with caution because 9 of the Master Teams received their initial
ICBT Training in April and only 3 of the Master Teams received their initial training in May
while, 4 of the Non-Master Teams received their initial training in April and 7 received their
initial training in May. Thereby giving the Non-Master Teams more of an opportunity to practice
ICBT during the first reporting month. By the second reporting month, the average number of
ICBT sessions was much closer between Master (M=3.5, SD=2.15) and Non-Master Teams
(M=3.36, SD=2.69) with a very small effect size (Cohen’s d=.06; r=.03). As time went by and
37

supervisory calls took place, Master Teams began to provide a greater average number of ICBT
sessions than Non-Master Teams (See Table 1). During month 8, when 2 of the 3 Master calls
took place, Master and Non-Master teams differed the most, with Master Teams providing an
average of 5.92 (SD=4.99) ICBT sessions and Non-Master Teams providing an average of 2.91
(SD=3.27) ICBT sessions with a large effect size (Cohen’s d=.71; r=.34). The number of ICBT
sessions individuals received differed between the Master and Non-Master programs. See Table
3 below.
Table 3. Number of ICBT Sessions Received by Master Status
Number of Sessions
Master Team
Non-Master Team
Consumers
Consumers
0
8.9% (N=5)
35.7% (N=25)
1-3

12.5% (N=7)

25.7% (N=18)

4-7

16.1% (N=9)

14.3% (N=10)

8-16

39.3% (N=22)

17.1% (N=12)

17 or More

23.2% (N=13)

7.1% (N=5)

For Master programs, 8.9% (N= 5) of the 56 individuals identified for the study had no
ICBT sessions; 12.5% (N=7) of individuals had 1-3 ICBT session; 16.1% (N=9) had 4-7
sessions; 39.3% (N=22) had 8 to 16 sessions; 23.2% (N=13) had 17 or more sessions. For nonMaster programs, 35.7% (N=25) of the 51 identified individuals had no ICBT; 25.7% (18) had 13 sessions; 14.3% (N=10) had 4-7 sessions; 17.1% (N=12) had 8-16 sessions; 7.1% (N=5) had
17 or more sessions. By the end of the project year, 62.5% of consumers (N= 35) on Master
teams had the recommended number of ICBT sessions (i.e., 8 or more) ICBT sessions while
33.4% of consumers (N=17) on Non-Master Teams had 8 or more ICBT sessions. (See Chart 1.)
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Treatment Outcomes by Master Team Status
Consumers on Master teams had an average AUS score decrease of .33 points (SD=.42),
while Non-Master Teams had an average AUS score decrease of .59 (SD=.64) points from the
first to last period each consumer was in the project. On the DUS, Master teams had an average
DUS score decrease of .11(SD=.55) points and non-Master Teams also had an overall DUS score
decrease of .11 points (SD=.56). For Master Teams there was an average PTSD score decrease of
1.64 (SD=10.44) points and for non-Master Teams there was an average PTSD score decrease
of .36 points (SD=6.02). For Master Teams, there was an average increase in hospitalizations of
4% (SD=.25) and ER increase of 6% (SD=.24). For Non-Master Teams there was an average
decrease in hospitalizations of 8% (SD=.39) and an ER decrease of 10% (SD=.4). See Table 4
below.
Table 4. Average Change Scores by Master Status and Sessions by 8 or more and 7 or Less
(standard deviation in parenthesis)
Average Change Score

Master Teams

Non-Master Teams

AUS Score Change

-.33 (.42)

-.59 (-.64)

DUS Score Change

-.11 (.55)

-.11 (.56)

Hospital Change

+.04 (.25)

-.08 (.39)

ER Change

+.06 (.24)

-.1 (.4)

-1.64 (10.44)

-.36 (6.02)

PCL Score Change

Within the Master group, consumers who received an average of 8 or more ICBT
sessions, the minimum recommended number of sessions, had an average AUS score decrease
of .35 points (SD=.66) from the time consumers entered and left the project. Within the NonMaster group, consumers who received an average of 8 or more ICBT sessions had an average
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AUS score decrease of .76 points (SD=.81). Within the Master group for consumers who
received an average of 7 or fewer ICBT sessions, there was an average AUS score decrease
of .23 points (SD=1.1). Within the Non-Master group for consumers who received an average of
7 or fewer ICBT sessions there was an average AUS score decrease of .59 points (SD=.91). See
Table 5 below.
Table 5. Average Change Scores in Points by Master Status and Sessions by 8 or More and 7 or
Less (standard deviation in parenthesis)
Average
Change Score

Master 8 or
more

Non-Master 8 or
more ICBT

Master 7 or less

Non-Master 7 or
less

AUS Score
Change

-.35 (.66)

-.76 (81)

-.23 (1.1)

-.59 (.91)

DUS Score
Change

-.14 (.67)

.22 (1.3)

-.28 1.45)

-.12 (.64)

Hospital
Change

+.13 (.34)

-.1 (.32)

-.05 (.61)

.03 (.52)

ER Change

+.16 (.37)

0

-.05 (.61)

-.19 (.58)

PCL Score
Change

+.47 (18.77)

+.35 (11.37)

+.21 (3.91)

-.24 (.57)

Within the Master group for consumers who received an average of 8 or more ICBT
sessions, on average there was a .14 (SD=.67) decrease in DUS score from the time consumers
entered and left the project. Within the Non-Master group for consumers who received an
average of 8 or more ICBT sessions there was an average DUS score decrease of .22 points
(SD=1.3). Within the Master group for consumers who received an average of 7 or fewer ICBT
sessions, there was an average DUS score decrease of .28 points (SD=1.45). Within the Non-
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Master group for consumers who received an average of 7 or fewer ICBT sessions there was an
average DUS score decrease of .12 points (SD=.64). See Table 5 above.
For consumers within the master group who received an average of 8 or more ICBT
sessions, there was an average PCL score increase of .47 points (SD=18.77) from the time
consumers entered and left the project. Within the Non-Master group for consumers who
received an average of 8 or more ICBT sessions there was an average PCL score increase of .35
points (SD=11.37). Within the Master group for consumers who received an average of 7 or
fewer ICBT sessions, there was an average PCL score increase of .21 points (SD=3.91). Within
the Non-Master group for consumers who received an average of 7 or fewer ICBT sessions there
was an average PCL score decrease of .47 points (SD=.99). These scores must, however, be
interpreted with caution as only a small percentage of consumers were administered the PCL
consistently over time and there was some confusion in PCL administration across teams.
Within the Master group for consumers who received an average of 8 or more ICBT
sessions, on average there was an average increase of 13% (SD=.34) in hospitalizations from the
time consumers entered and left the project and an average increase of 16% in ER visits
(SD=.37). Within the Non-Master group for consumers who received an average of 8 or more
ICBT sessions there was a 10% (SD=.32) decrease in hospitalizations on average and no change
in ER visits. Within the Master group for consumers who received an average of 7 or fewer
ICBT sessions, on average there was a 5% (SD=.77) decrease in hospitalizations a 5% (SD=.61)
decrease in ER visits from the time consumers entered and left the project. Within the NonMaster group for consumers who received an average of 7 or fewer ICBT sessions, there was a
19% (SD=.58) average decrease in hospitalizations and 24% (SD=.57) decrease in ER visits.
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Out of the 107 individuals who initially screened positive for PTSD and SUD, 38 of those
individuals had clinically significant alcohol use as determined by a score of “3” or higher on the
Alcohol Use Scale among the Master and Non-Master teams. For those 38 individuals, 21
received 0 to 7 ICBT sessions and had an average decrease of 1 point (range = -3 to 0; SD=1.1)
on the alcohol use scale. The remaining 17 individuals with an AUS score above a “3” received 8
or more ICBT sessions and had an average decrease of 1.35 points (range = -3 to 0; SD= 1) on
the AUS. Thus demonstrating a larger decrease in AUS score for individuals receiving a greater
amount of ICBT with a medium effect size (Cohen’s d=.33; r=.16). 18 of the 38 individuals with
AUS scores 3 or higher were on Master Teams and of those 21 individuals 9 received 0 to 7
ICBT sessions and 12 received 8 or more ICBT sessions. Of those 9 who received 0 to 7 ICBT
sessions, they had an average AUS score decrease of .56. Of the 9 individuals who took part in 8
or more ICBT sessions there was an average decrease of 1.22 (-3 to 0; SD=1.09) points.
Of the 20 individuals who were on Non- Master teams 9 received 0-7 ICBT sessions and
had an average overall decrease in AUS score of 1.33 (range= -3 to 0; SD= 1.07). Of the 9 NonMaster Team consumers who received 8 or more ICBT sessions, there was an overall average
decrease in AUS score of 1.55 points (-3 to 0 SD= .93). The mean AUS score difference between
Non-Master consumers with AUS scores above 3 who received either 0-7 and 8 or more ICBT
sessions showed a larger decrease in AUS scores for those individuals receiving 8 or more ICBT
sessions with a small effect size (Cohen’s d=.22; r=.11). See Table 6 below.
Table 6. Average Change Scores by Master Status and Sessions by 8 or More and 7 or Less for
Individuals with Clinically Significant Alcohol Use (standard deviation in parenthesis)
Average
All Teams
All Teams 7 or Master
NonMaster
NonChange
8 or more
less
Teams 8 or
Master
Teams 0- Master
Score
more
Teams 8
7
Teams 0-7
or more
AUS Score -1.35 (1)
-1(1.1)
-1.22 (1.09) -1.55 (.93) -.56
-1.33(1.07)
Change
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Out of the 107 individuals who initially screened positive for PTSD and SUD, 46 of those
individuals had clinically significant drug use as determined by a score of “3” or higher on the
Drug Use Scale among the Master and Non-Master teams. For those 46 individuals, 24
participated in 0-7 ICBT sessions and 22 participated in 8 or more sessions. Of the 24 who
participated in 0-7 sessions, there was an overall average score increase on the DUS of .5 points
(range=-3 to 1; SD=1.59). Of the 22 who participated in 8 or more sessions, there was an overall
DUS score increase of .77 points (range = -3 to 2; SD=1.41). For Master Teams, 11 were
involved in 0-7 sessions, with an overall DUS score increase of .18 (range=-2 to 4 SD= 1.78) and
15 were involved in 8 or more visits with an overall DUS score increase of .6 (range=-2 to 3;
SD=1.4). 13 Non- master team participants had 0-7 sessions, with DUS increase of .77 points
(range = -1 to 4; SD=1.42). For Non-Master Teams 7 individuals participated in 8 or more ICBT
sessions with a DUS point increase of 1.14 (range =-1 to 3; SD=1.46). See Table 7 below.
Table 7. Average Change Scores by Master Status and Sessions by 8 or More and 7 or Less for
Individuals with Clinically Significant Drug Use (standard deviation in parenthesis)
Average
All Teams 8 All Teams 7 or Master
NonMaster
NonChange
or more
less
Teams 8 or
Master
Teams 0- Master
Score
more
Teams 8 or 7
Teams 0more
7
DUS
+.77 (1.41)
+.5 (1.59)
+.6 (1.4)
+1.14(1.46 +.18
+.77
Score
)
(1.78)
(1.42)
Change

Supervisory Calls & Fidelity
Differences in supervisory call participation and content between Master and Non-Master
Teams were captured by evaluating the notes taken by the call facilitator from each supervisory
call. During the calls, teams reported the number of clinicians providing ICBT and number of
consumers receiving ICBT at the time the calls took place. In addition, teams were rated on their
fidelity to the ICBT model on a scale from 1 to 7 with 1 being “not at all;” 4 being “somewhat;”
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and 7 being “extensively.” Data for 9 of the 12 Master Teams was available for the first
supervisory call and data for 11 of the 12 Master Teams was available for the second Master call.
Data for 9 of the 11 Non-Master Teams was available for the first supervisory call and data for
11 of the 11 Non-Master Teams was available for the second supervisory call.
During the first set of supervisory calls, the average number of clinicians providing ICBT
on each team was 1 (SD =.87) for Master clinicians and 2.33 (SD=2.29) for Non-Master
Clinicians. During the second call, the number of clinicians providing ICBT on Master teams
rose 2.18 points to 3.18 clinicians per team (SD=1.89). For non-Master Teams, the number of
clinicians per team providing ICBT rose .21 points to 2.55 clinicians (SD=1.69).
During the first set of calls, the average number of consumers receiving ICBT on each of
the Master Teams was 1.33 (SD=1.41) while the average number of consumers receiving ICBT
on the Non-Master Teams was 2.33 (SD=2.24). By the time the second set of calls took place,
the average number of consumers receiving ICBT on Master Teams rose by 1.49 consumers to
2.82 consumers (SD=.98). The average number of consumers receiving ICBT Non- Master
Teams rose by .58 consumers to 2.91consumers (SD=1.64).
During the first set of supervisory calls, the average fidelity score for the Master Teams
was 4.33 (r=1-7, SD=4.23) and the average fidelity score for non-Master Teams was 4 (r=1-7,
SD=2.5). During the second set of supervisory calls the average fidelity score of Master teams
decreased by .1 points to 4.23 (r=2-6, SD=1.29). During the second set of supervisory calls,
average Non-Master Team fidelity rose by .36 points to 4.36 (r=1-7, SD=1.57).
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Chapter 5: Discussion, Limitations, Study Implications
Discussion
Importance of Motivation
This study demonstrates the benefits and challenges inherent in developing an
implementation protocol in a community based setting serving individuals with serious mental
health and co-occurring substance use conditions. The combination of training, phone
supervision and data collection appeared to create an environment for ACT Teams to try a new
clinical tool. However, some teams were less eager to provide ICBT than others. Apparent in the
data and based on observations, teams with motivated leaders and/or members more regularly
provided ICBT and noted its clinical benefits. While teams who initially felt the ICBT training
and data collection was a chore that would not benefit the people they serve, were less likely to
provide ICBT.
Given the large role motivation appeared to play in the provision of ICBT, it is
unfortunate that a more formal measure of motivation was not introduced into the study and
makes interpreting the data quite complex given that those individuals who signed up for Master
Training appeared more motivated than their counterparts that forwent the additional training
hours. At the same time, there appears to have been an interactional effect that the Master
Training plus motivation had on ICBT sessions provided. Specifically, even though Master
teams were more likely to sign up for additional training, based on the data, it seems as though
the training also impacted their likelihood of providing ICBT. Similarly, if teams had not been
offered formal training in ICBT, motivated teams would likely not have started to provide ICBT
on their own. Thus, pointing to the importance of future research focusing on increasing staff
motivation in the context of targeted training efforts. Though, perhaps research is warranted in
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the area of increasing staff motivation alone, to determine if increases in motivation would lead
individuals or organizations to seek out training in EBPs.
While staff motivation has been largely discussed in the organizational psychology
literature (Weiner, 2009), it is only just beginning to become integrated into the concept of EBP
implementation in mental health settings (Williams et al., 2013). Though implementation
researchers have addressed motivation in their work (Proctor et al., 2009), more attention to
motivation and in particular employee values may be worth exploring more when implementing
a new practice in a behavioral health setting. Specifically, research has shown that individuals
are the most likely to change when the change aligns with their personal values (Sheldon &
Kasser, 1998). Furthermore, change is also more likely to take place, when individuals feel
autonomous and believe that the change behavior is coming from one’s self (Deci & Ryan,
2000). All of these motivational and change predicting factors appeared relevant to the current
study despite inclusion of motivation or values based measures.
In some ways, we did make efforts to determine if specific individual characteristics (e.g.
age, level of education, years of experience, etc) were relevant to implementation/motivation,
yet, teams were uncooperative in returning staff demographic questionnaires to us. It is unclear if
this was due to these questionnaires asking about demographics or related to a more general
ICBT burnout and ease with which teams could opt out of a voluntary task. Based on
observation, motivation appeared highest in team members who were new to the field, and just
starting out in their positions, followed by seasoned team leaders with interest in enhancing their
teams clinical skills based on their own clinical interests. While it would be unreasonable to
create a workforce comprised only of certain types of employees, it would be worth exploring
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how and why some employees are more motivated than others to determine ways to increase
motivation among individuals with less motivation.
While the internal staffing patterns of Master and Non-Master teams were similar as a
result of their being a standard ACT staffing pattern, Master clinicians tended to fall in one of
two groups. Specifically, Master clinicians tended to be frontline staff at the beginning of their
careers or seasoned program directors. And in both of these groups, there was a very high level
of energy and commitment to the individuals they served. This enthusiasm, however, was not
seem across Non-Master Teams and was also not seen among some of the staff who worked on
the Master Teams but were not Master clinicians. Thus it appeared that some type of internal
drivers within the Master clinicians was driving the uptake of ICBT and desire to become Master
teams. Furthermore, for teams that had enthusiastic leaders (i.e., program directors) the effects
trickled down to the entire team, thereby allowing for additional ICBT sessions to take place.
Past data supports the notion that internal clinician characteristics and strong change
leaders lead to increased treatment uptake (Torrey et al., 2001). In particular and as evidenced in
this study, team members that believed ICBT would help their clients were more likely to sign
up for Master training and provide more ICBT sessions. This was contrasted with clinicians and
team leaders that believe their clients were “too sick” for CBT. Teams that thought they either
new the CBT model, or didn’t believe the model would work for their clients provided less
ICBT, were less likely to become Master clinicians and were more likely to submit data late or
be non-responsive to data coordinator. As is consistent with other research, individuals are much
more likely to want to learn and implement an evidence based practice if they see it as an area of
improvement for themselves and as a benefit to their clients (Torrey et al., 2001).
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The nature of ACT Team work in NYC is another variable that likely influenced
motivation and commitment to the ICBT model. ACT team work is exceptionally difficult as
evidenced by staff reports and a very high staff turnover rate. Often for staff who stay on the
teams and are not promoted to program directors, a sense of bitterness may arise as a result of the
daily challenges the work imposes with no reward. As a result of this, new staff are often the
most motivated on ACT Teams. These new staff, tend to fall into three categories; those who
leave after about one year for a more senior position in another social service sector, those who
become promoted to a program director on the ACT Team, or those who stay on the team in their
current role. Those who become promoted or move on, thus appear to be more enthusiastic about
their work and helping individuals with SMI. In fact, on the Master Teams, two of the Master
clinicians moved on to higher level positions in different social service sectors before the project
year ended. These two clinicians, were anecdotally two of the most motivated, and dedicated to
the ICBT model.
Another important factor separating Master and Non-Master Teams apart was the number
of AOT consumers on their teams. Specifically, Master Teams had fewer AOT consumers than
Non-Master Teams. Providing care to individuals on AOT proves very challenging as there are
increased clinical and administrative demands. Clinically individuals on AOT court orders tend
to be more challenging to engage as they often have AOT orders due to a history of treatment
non-adherence. Thus, ACT Teams who work with these individuals need to work harder to
engage these individuals and may feel less satisfied about their work with these individuals do to
the slow progress and constant engagement techniques they need to employ to ensure these
consumers see the ACT Teams. Furthermore, AOT court orders require ACT Teams to take
specific measures to search for AOT consumers when they go missing, something that isn’t rare.

48

These measures, while necessary, burden staff and require specific documentation that takes time
to complete. Additionally, AOT consumers require additional paperwork overall, and ACT
Teams often need to help these individuals attend their AOT court dates, which is very time
consuming for ACT Team workers For teams with additional AOT consumers, the burden of
added work could make the task of learning and implement a new treatment daunting.
The additional work associated with AOT does not fall evenly across ACT Teams and
may therefore contribute to overall staff bandwidth to do additional work. Staff on ACT Teams
with additional AOT consumers may become stressed out more easily and feel less engaged in
their work if they do not have the right support. Given the high intensity of ACT work, AOT
consumers pose a clinical and administrative challenge for teams that are already overwhelmed.
Therefore, teams with fewer individuals with AOT court orders are at an advantage in that they
have less administrative responsibilities and are treating individuals who are less challenging
clinically. This difference may allow for teams with fewer AOT consumers to feel less
overwhelmed and motivated about their work, which may explain why teams with fewer AOT
consumers would sign up for the Master Training.
While the majority of the data from this study do not isolate benefits of the Master
training alone, it does highlight the importance of staff motivation and eagerness to gain added
knowledge in the provision of a new treatment modality. Together, it appears that some
combination of staff motivation, the Master calls and the earlier supervisory calls lent themselves
to the provision of ICBT sessions. Staff motivation seems to explain the early differences
between the Master and Non-Master Teams as well as the Master Teams volunteering for
additional training. The initial supervisory calls also seem relevant in that ICBT sessions went up
for both Master and Non-Master teams when ICBT calls took place and seemed to go down as
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time passed from when the ICBT calls took place. The Master Calls also appear important
because the data showed that the greatest difference in the number of ICBT session that were
provided by Master and Non-Master Teams with Master Teams providing more sessions,
occurred when the Master Calls took place. Thus, it seems these three elements (motivation,
supervisory calls, and master calls) were important in enabling staff to provide ICBT sessions.
Much of the observations made in working with the ACT Teams was in line with past
research independent of progress made by clients and the amount of ICBT provided.
Specifically, clinicians demonstrated great fears and concerns providing trauma treatments.
While ICBT is not exposure based and even though clinicians attended ICBT training, many
were hesitant to practice ICBT because they feared they would retrigger their clients trauma
histories, which would lead to increased symptomology. Clinicians expressed fears that by
merely mentioning trauma their clients would become unstable despite evidence discussed
earlier that points to the contrary. Similarly, even though ICBT is not exposure therapy, because
ICBT involves trauma, many clinicians did not understand that ICBT did not involve exposure
despite numerous attempts at education on the supervisory calls and through individual and
group contact with teams.
Other clinician fears included a sense that clients were “too sick” to receive ICBT. Many
clinicians shared that they thought clients with psychosis could not grasp CBT concepts despite
evidence that suggests otherwise. While the supervisory calls allayed some of these fears, for
some teams the idea that ICBT was not appropriate for their clients was maintained throughout
the entire project year despite continuous attempts to explain how ICBT works and its benefits.
This continued fear or reluctance to use ICBT exemplifies some of the great and many barriers to
implementing EBPs especially among clinicians who have very strong thoughts and opinions
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regarding the individuals they serve. Thus, future studies may want to think about, explore and
address preconceived notions about clients prior to implementing and disseminating and EBP.
In addition to exploring and addressing preconceived notions about clients upfront,
evidence suggests that the way an EBP is packaged and sold is very important (Rogers, 2003).
While attempts were made to package ICBT as user friendly and applicable to ACT clients,
based on staff fears and concerns regarding ICBT uptake, more marketing could have been done
early on. By better assessing staff competence and interest in ICBT on a trauma treatment in
general, the package developed for the ACT Teams could have better sold ICBT. If resistance
were predicted early on, initial training sessions could have been longer and taken place in
smaller groups to leave time and space to discuss concerns about ICBT openly thereby assuaging
fears and motivating staff to use ICBT.
Another approach to enhancing ACT Team use of ICBT could have been achieved by
better demonstrating the ease with which ICBT could be implemented in ACT settings. The
initial ICBT training was given by an ICBT expert with little ACT Team knowledge. While the
initial training explained ICBT well it neglected to demonstrate the ease with which it could be
used on ACT Teams. According to Rogers (2003), the easier an innovation appears to be, the
more likely it will be used. An adapted version of the initial ICBT training was offered to new
staff at several points during the study year and the new training was specifically tailored to ACT
Teams. These trainings received more positive reviews of ICBT and several of the staff who
attended these trainings went on to become Master clinicians. As a result of adapting the training
by focusing specifically on ICBT for ACT and demonstrating its applicability and ease of use,
there were more favorable results.
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In addition to adapting the marketing and training for this study, it was apparent that
strong change leaders were pivotal in the implementation of ICBT. As has been found in the
research having change leaders who are interested and excited about an EBP strongly predicts
implementation outcomes (Aarons et al., 2012; McGovern, Lambert-Harris, McHugo, Giard &
Mangrum, 2010; Torrey et al., 2011; Sylvain & Lamothe, 2013). In this study, teams that had
eager Team Leaders and involved management provided ICBT more regularly and were more
likely to volunteer for the Master training. Unfortunately, however, in addition to strong change
leaders financial support also often helps with EBP implementation – and none of our teams
received additional financial support to implement ICBT.
Despite the lack of financial support or incentives, as expected teams did respond well to
supervision, especially those teams that had strong change leaders and motivated staff. While
this study did not include a measure of motivation, past research shows supervision is
particularly meaningful within the context of agency buy-in and workflow changes (Brunette et
al., 2008; Rapp, Goscha, & Carlson, 2010). The importance of this combination was apparent for
our teams though difficult to reflect in the data. Based on observations of teams, it was clear that
supervision was the most meaningful to motivated teams that were willing to change their
workflow to incorporate ICBT. Again speaking to the importance of motivation in dissemination
and implementation initiatives.
While it may be assumed that teams with greater fidelity to the ICBT model would be
more motivated provide more ICBT sessions, this did not seem to be the case. Despite the greater
number of ICBT sessions provided by Master Teams, initial fidelity to the ICBT model was
similar for Master and Non-Master Teams. Fidelity was measured by the ICBT supervisory call
facilitator who was the same across all calls. Based on her ratings, during the initial two
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supervisory calls Master and Non-Master Teams demonstrated a similar fidelity to the model,
thereby indicating that early on ICBT sessions quality was likely similar across the two groups.
This shows that while, Master Teams provided more ICBT sessions it was not the result of better
understanding the ICBT model, but again perhaps was the result of motivation to provide the
actual sessions. Given the addition of the Master calls for Master Teams and added information
learned, over time Master Teams may have increased fidelity to the ICBT model but because we
did not track fidelity over time this information is unknown.
Fidelity to the model is an interesting concept to think about in this study as it seemed
that fidelity was mostly based on past the training experiences teams had and not motivation or
other factors. The initial training and supervisory calls did appear to be uniformly helpful across
the Master and Non-Master Teams and past CBT experience seemed related to fidelity on
supervisory calls. However, familiarity with CBT did not seem related to interest in Master
training or implementation as is consistent with the notion that uptake of a treatment model is
more likely to take place when clinicians see a need for a particular training (Torrey et al., 2001).
It’s also perhaps true that as Master Teams learned the model in more and more depth,
they became better at integrating ICBT into their usual practice and not documenting their work
as strictly ICBT. This may explain why ICBT sessions began to decline after the three Master
calls took place. However, it may also be true that on-going supervision is needed regularly and
continuously for a treatment to be used consistently. While, there were some short-term benefits
in the provision of ICBT sessions during period 8, when two ICBT Master Calls took place, they
were not sustained overtime and other factors or ways to increase implementation need to be
identified. Perhaps, one way to do this is to work with clinicians to show a continued need to
practice and enhance learning around the specific therapy technique that one is looking to
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implement. Again, this points to a need for a more nuanced understanding of motivation in
implementation and dissemination research.
Successes and Failures of Master Training
Despite concerns regarding motivation, burnout and overall workload, ACT Teams
provided a lot of ICBT and clinicians reported thinking about and approaching the individuals
they serve differently. While there were some teams that provided very little ICBT, maintained a
non-recovery stance (e.g., stating that individuals on ACT Teams were “too sick for CBT”) and
lacked interest in the treatment, a considerable number of teams made real changes in the way
they provided assessments and treatment. Individual clinicians shared success stories and were
appreciative of learning this treatment, reporting that they had been improving their relationships
with their clients through engaging them in a structured treatment. Interestingly, teams reported
that even though at times, AUS, DUS, and Stage of Change scores weren’t changing, they
observed clients becoming more open to treatment, more reflective of their situations, and better
able to regulate emotions. While the study did not capture these outcomes, they are important
considerations for ACT Teams in that engagement is reported as a large challenge facing these
teams. Providing a treatment that allows clients to better relate and interact with staff not only
helps them move toward recovery but makes clinicians like their jobs better.
In this study, Master Teams provided a greater number of ICBT sessions compared to
Non-Master Teams overall and throughout the project year. Again, there is a clear element of
motivation associated with the Master Teams’ performance, however, the Master calls
themselves appeared to influence the amount of ICBT provided by the Master Teams. This was
seen when looking at the data, which showed that during the months Master calls took place,
more ICBT sessions were provided. In fact, on average Master Teams provided the most ICBT
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sessions during the month that the first two Master calls took place. During this month, Master
teams and Non-Master teams also had the greatest difference in terms of ICBT sessions
provided, with Master Teams providing more ICBT sessions than Non-Master Teams. This large
difference demonstrates the importance of ongoing support once a training has taken place in
addition to highlighting how without regular ongoing support the effects of training are
diminished. Despite, Master Teams continuing to provide more ICBT sessions on average than
Non-Master Teams for the remainder of the project year, the amount of ICBT provided by them
was the most when they had two support calls in one single month.
Given that Master Teams were self-selected, there is still question as to whether or not
Master Teams were more likely to provide more ICBT sessions independent of the Master
Training. At first glance Master Teams appeared to have an advantage from the start in that they
provided a greater number of ICBT sessions on average during the first reporting period when
compared to Non-Master Teams. While this data make it appear as though Master Teams had an
advantage early on, differences in the provision of ICBT sessions may have been attributed to a
greater number of Master than Non-Master Teams being introduced to ICBT during the first part
of the reporting period.
Due to training and time constraints, not all Teams were trained the same day and by
what appears to have been chance, most of the teams that later volunteered to be Master Teams
were trained during the first training sections that took place two weeks before the second set of
training sections. This difference in training dates gave those teams trained earlier more exposure
to ICBT early on and a greater chance to provide ICBT during the first reporting period. This
difference in training date may thus explain why during the second reporting period Master and
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Non-Master Teams provided similar amounts of ICBT. And thus give added support to the idea
that on going supervisory support aids in the provision of an EBP after training.
In some ways, it is interesting that Master Teams tended to receive their initial ICBT
training early on and points to the importance of ensuring initial training sessions are equivalent
in this type of work. For instance, during the early training dates there were more DOHMH staff
present at the trainings, which might have influenced the atmosphere of the training. DOHMH
staff may have led the trainer to perform better or for teams to pay more attention and in turn
learn more about the treatment. If teams learned more about ICBT because the trainer did a
better job or because they paid more attention, they may have been more interested in further
education because they would have been better able to see the benefits ICBT would have on their
work. Based on observation, it seems more likely that teams were more influenced by staff
presence than the trainer, though the theory that the better teams understood ICBT the more they
would want to further their understanding holds. Specifically, it seems likely that teams who
were trained in the presence of DOHMH staff who oversaw their programs would have paid
more attention in the training sessions.
Once all teams were trained, by the second reporting period, Master and Non-Master
Teams seemed to be providing similar amounts of ICBT. Arguably, this time would be a better
base from which Master and Non-Master Teams could be compared. As time went on, however,
Master Teams began to provide a greater number of ICBT sessions on average – even prior to
the start of the Master Training. The greater ICBT uptake seen by Master Teams again, was
likely related to motivation and perhaps a greater openness to ICBT supervisory calls. The idea
of their being an interactional effect wherein motivation combined with other factors such as the
initial supervisory calls would lead to greater amounts of ICBT seemed apparent here.
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Considering that Master Teams self-selected to receive additional training, it makes sense that
they would be more responsive to ICBT supervisory calls and more interested in providing
ICBT.
Master Teams may have started out more strongly than Non-Master Teams based on the
initial training date, however, this does not explain the reason that Master Teams started to
perform better in terms of ICBT sessions provided prior to the Master calls taking place.
Perhaps, one possibility for the greater number of ICBT sessions provided by Master Teams after
period two and prior to the Master calls may be that Master Teams responded better to the initial
supervisory calls and thus were more likely to sign-up for the Master calls as a result. Similarly,
another possibility is that Master Teams may have been more inclined to want to impress the
trainers on their first set of supervisory calls, thereby providing more ICBT sessions as a result of
the supervisory calls taking place. In this way, these teams who later selected themselves to
become Master Teams may have not only been motivated to learn ICBT because of personal
and/or professional interest but perhaps out of a sense of obligation or desire to perform well.
Anecdotally, it is also true that the teams that volunteered to be Master Teams, were more likely
to submit their data on time and were more responsive to the principal investigator generally.
This seems inline with organizational psychology research, which points to agreeableness as a
trait related to performance and uptake of a new practice or tool (Devaraj, Easley, & Crant, 2008
& Longwe, Lord & Carrillo, 2015).
Despite speculation that Master teams may have been more responsive to supervisory
calls or particularly interested in impressing supervisory call facilitators, when looking at data
from the calls themselves, Non-Master Teams actually appeared to report higher rates of ICBT
fidelity and more clinicians providing ICBT than Master Teams. This finding is surprising in that
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one would think teams that later became Master trained would be more eager and open to
providing ICBT in an adherent way early on. It is possible that Non-Master teams were actually
those that learned and understood the model better and were thus less interested in further ICBT
training.
The most striking difference in ICBT sessions between Master and Non-Master Teams
took place during the eighth reporting period when the first two Master calls took place. During
period 8 on average Master Teams provided more ICBT sessions than Non-Master Teams. The
increased difference in ICBT sessions provided by Master teams during period 8 seems to
indicate that the 2 Master calls that took place during that reporting period may have led to an
increase in ICBT sessions for Master Teams. Furthermore, it seems as though having scheduled
two supervisory calls in close proximity to one and other was particularly helpful as indicated by
a decrease in ICBT sessions for Master Teams during period 9 when only one Master call took
place.
Even though ICBT sessions decreased on average during period 9 for Master Teams,
ICBT sessions also decreased on average during period 9 for Non-Master Teams. ICBT sessions
dropped again during period 10 when there were no longer any Master Calls taking place and as
the project year was ending. The increase in ICBT sessions during period 8, thus indicates some
benefit to having calls in close proximity to one and other. At the same time, having a Master
call during period 9 may have been an added benefit in that Master Teams continued to provide
more ICBT sessions on average than Non-Master Teams. An interesting finding, however, was
seen during the last reporting period when the difference in average ICBT sessions provided by
Master and Non-Master Teams decreased. During the last reporting period, average ICBT
sessions decreased for Master Teams but increased for Non-Master Teams. Perhaps Non-Master
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teams decided to try harder as the project year came to a close given that many of the NonMaster Teams did not provide ICBT on a regular basis. For Master Teams it is unclear why
average ICBT sessions dropped, but the drop was so minimal that it likely indicated sessions
were starting to plateau.
Disappointingly and an apparent failure of the Master Training, was seen in the clinical
outcomes associated with Master Teams versus Non-Master Teams. Consumer drug, alcohol,
stage of change, PTSD, ER and hospital outcomes for Master and Non-Master Teams varied
between teams. For individuals with alcohol use above a score of 3 on the AUS at the start of
their time in the project, Non-Master team consumers had greater decreases in alcohol use than
Master Team consumers overall. This was also true of all consumers on average, not just those
with scores of 3 or higher on the AUS.
For consumers on Master and Non-Master teams, individuals who received more ICBT
sessions also had greater AUS score decrease. This finding was expected, but again, on average,
Non-Master Teams performed better than Master Teams in terms of AUS score decreases when
more sessions were provided, which was not expected. This finding suggests that there was
perhaps some added benefit to the type of ICBT or other additional substance use treatment
provided by Non-Master Teams. These findings put into question the value of the Master calls on
the quality of the ICBT provided. While, greater numbers of ICBT sessions were associated with
better AUS score outcomes, these associations favored Non-Master Teams. At the same time,
because more sessions meant better outcomes, the value of the Master calls cannot be entirely
negated based on this finding in that Master Teams did provide more ICBT sessions on average.
What is somewhat discrepant from the anticipated hypothesis is that AUS scores seemed
to go down more for consumers on Non-Master Teams. While it was expected that Master
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Teams would have better treatment outcomes, for alcohol use, this was not the case. It is possible
that Non-Master teams were better versed in providing substance use treatment, which may
explain why they did not volunteer for additional training. Or perhaps, because Master teams
received more training, they may have been assessing for alcohol use more accurately. Another
possibility is that is Master teams were focusing on trauma more than Non-Master teams, alcohol
use, though part of ICBT may have received less attention than Non-Master Teams that may
have focused primarily on substance use.
ICBT Impact
The data collected as it related to consumer outcomes was mixed, which may have been
the result of the data we collected, the mechanisms by which we collected the data, the treatment
itself or some combination. One standard observation made in the data was that greater decreases
in alcohol use were seen for consumers with more significant AUS scores. This makes sense in
that higher AUS scores likely led clinicians to focus more on alcohol use and given the higher
scores there was more room for those scores to go down. For consumers with AUS scores of 1,
or 2, AUS scores may not have needed to go down in that scores of 1 and 2 indicate no clinical
problem with alcohol use. This is important to consider in that it points to perhaps a greater
utility of ICBT use for individuals with more severe substance use needs.
Despite AUS score decreases for individuals on Master and Non-Master Teams, DUS
score decreases were very slight from the start to end of the project year. Even more surprisingly,
when looking at DUS scores, fewer ICBT sessions appeared to be associated with better DUS
score outcomes. Outcomes looked best for consumers on Master Teams who received 7 or fewer
ICBT sessions. This finding does not seem to make sense given that we expected both alcohol
and drug use scores to go down. When only looking at individuals with clinically significant
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DUS Scores (3 or higher), the picture becomes even more complicated. For individuals receiving
7 or fewer ICBT sessions or those receiving 8 or more, DUS scores increased. This was also true
regardless of whether consumers were on Master or Non-Master Teams, with average DUS
scores going up regardless of Master status.
DUS score changes overtime in the two groups was in contrast to what was expected to
happen for individuals receiving ICBT or in the study in general. It was expected that DUS
scores would go down overtime with AUS scores and as treatment progressed. Perhaps as
individuals decreased alcohol use or addressed PTSD symptoms, increases in drug use followed
to help individuals cope with increased anxiety. However, we do not have the necessary data to
determine why these increases in DUS scores were found. Research does not suggest that as one
substance decreases another arises and research has shown that as PTSD symptoms subside
substance use will subsequently be reduces (Hien et al., 2009).
One challenge faced as part of this study was the lack of attention to PTSD symptom
assessment by all teams. And therefore, this did not allow for their to be an exploration of
whether the reduction of PTSD symptoms led to subsequent substance decreases or increases
given how the data looked. While teams were regularly encouraged to administer the PCL, the
length of the instrument appeared to impede teams from regularly assessing PTSD symptoms.
Despite monthly prompting, most teams sporadically assessed for PTSD using the PCL, and
therefore PTSD scores were not captured regularly. As such, the PTSD data collected appears to
be somewhat unreliable.
It is unfortunately not surprising that ACT Teams did not regularly administer the PCL
given that many teams did not want to be treating trauma and since the PCL requires more time
than the AUS and DUS. If teams felt more comfortable with trauma treatment and also had more
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time for assessment, the results here may have looked different. As a result of team’s trepidation
to talk about trauma, it is perhaps likely that trauma treatment was not at the forefront of teams’
minds and perhaps led to such varied average substance use outcomes. If teams were more
comfortable discussing trauma and implementing CBT techniques to reduce PTSD symptoms,
drug use may have been impacted more positively. Anecdotally, for some teams, particularly
some Master Teams, those that were more open to assessing and talking about trauma reported
better consumer outcomes. Again, however, this was not captured in the summary data, which
included both Master and Non-Master Teams that expressed reluctance to address trauma.
Hospital and ER data in this study were also difficult to analyze in that average changes
in hospital and ER data were minuscule across time. The only group that demonstrated an
average decrease in hospitalizations was for Non-Master Teams that provided 8 or more ICBT
sessions. However, the decrease was very small and during that same period ER visits did not
change for this group. One challenge to the way this data were collected was that I only asked
teams to report whether or not a consumer went to the hospital or ER for psychiatric reasons
each month. Despite wanting to capture multiple hospitalizations and ER visits in a month,
DOHMH staff who oversee ACT Teams were concerned about not wanting to overburden ACT
Team members and asked for me to capture the data in this way. At the same time, and a positive
thing, it did not seem as though many ICBT consumers were going to the hospital, which
demonstrates the benefits of the ACT Team work as a whole.
The uneven outcomes across Master and Non-Master Teams when assessed comparing
teams that provided 8 or more or 7 or fewer ICBT sessions does not paint a clear picture of the
benefits associated with ICBT. While individuals in the groups receiving 8 or more ICBT
sessions seemed to make greater improvements across some domains, these benefits were not
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uniform nor were there uniform differences between Master and Non-Master data. These
findings point to the great difficulties inherent in bringing EBPs into real world settings. While
teams seemed to receive sufficient training up front, fidelity was not captured over time nor were
there standardized fidelity checks, which makes analyzing outcome data even more complicated
in that there is no way to find out if what ACT Teams were reported as ICBT sessions were in
fact true ICBT sessions.
EBP Limitations
As mentioned in the literature review, some clinicians lack confidence in EBPs as they
are conflated with ESTs and clinicians question manualized treatments and the RCTs that
support their efficacy and effectiveness. While ICBT is a manualized treatment made up of
several EBPs, its effectiveness once removed from a controlled study is subject to critique.
Anecdotally ICBT clinicians reported that ICBT helped consumers become more engaged and
allowed for greater therapeutic work, however, the data here is not overwhelmingly supportive of
the treatment as compared to treatment as usual. Thus, it is worth thinking about what it means to
bring an EBP or EST into a non-controlled setting, arguments against EBP and EST language
and the notions of common factors related to good therapeutic interventions.
It is reasonable to assume that the clinicians trained in this study did not receive the same
extensive type of treatment or fidelity check as those who were in studies that gave credence to
ICBT’s effectiveness. While all ACT Team members received a one full day of training in ICBT,
this training was not specifically created for ACT Teams and the work they do. Thus, attention
was likely lost in these training settings, as was evidenced by one staff member who was actually
observed going in and out of sleep. These trainings were also large and as such did not allow
much time for personalization or checks to ensure staff understood the content. Furthermore,
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apart from observational data related to fidelity on the supervisory calls, this study lacked
adequate fidelity checks and as such the quality of the ICBT is to be questioned here. While
these flaws may have led to an adulterated version of ICBT, they are important to consider in
that this study likely emulates real world adoption of EBPs or ESTs and points to the difficulties
inherent in implementing an EBP. No matter how good a treatment is, there is no guarantee
outside of taped therapy sessions to ensure adherence to the model – something that would be
very difficult for community providers to adopt across all clinicians in a community mental
health setting.
Once an EBP is taken out of a controlled research setting, much can go awry and speaks
to concerns that prominent psychologists have regarding the emphasis on EBPs and EBP/EST
language (Wachtel, 2010). Requirements for treatments to be manualized and funding only being
given to groups practicing EBPs, is thus flawed. Specifically, EBP language and rhetoric
assumes that if one is using CBT, for example, they are practicing an ideal treatment, however,
CBT means many things, and without proper supervision and adherence that which the clinician
is practicing may as well be treatment as usually. Consider, on the other hand, a clinician not
practicing and EBP per se, but a clinician with many years of experience and knowledge of many
effective practices that he/she has learned from research, supervisors and individual cases – it is
likely that this individual is providing care that is relevant, meaningful and leads to positive
outcomes. However, because this individual isn’t practicing an EBP or EST as we know of them
(i.e., a specific treatment), their work may be subject to scrutiny by insurers and/or oversight
entities if not documented correctly.
Another pitfall of EBPs that may have impacted this work is related to the “common
factors” associated with beneficial psychotherapy. These factors include empathy, the alliance,
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therapist positive regard and genuineness (Norcross, 2011). While these factors encompass the
spirit of ICBT and these factors were discussed in our trainings, they weren’t done so
systematically and more focus and attention was placed on the treatment itself. While teaching
common factors takes place in graduate schools and intensive psychotherapy training, they are
not easy to teach in a time limited training even with supervision especially when the focus is on
a specific treatment modality. Thus, in this way, the effects of ICBT may have been impeded
somehow by the lack of focus on common factors. And since we did not control for these factors,
we cannot determine their impact on the results.
Limitations
This study had a number of limitations. The greatest limitation was that the study did not
control for any of the extraneous variables that set the Master and Non-Master Teams apart.
While the basic composition of most teams was known, individual provider variables were not
known or explored. Despite trying to survey Teams to better understand specific individual
provider variables, most Teams did not respond to this request. This request was made at the end
of the project year at which time most teams were tired of submitting data. This lack of
responsiveness was another limitation to the study overall, as most of the ACT Teams are very
busy and feel overworked thereby making requests for data or ability to engage in activities that
are in addition to the ACT model very challenging. However, even if we had more specific
details, past research shows that individual provider variable including work experience are not
particularly relevant to EBP adoption (Lindholm, Koivukangas, Lassila & Kampman 2015).
Another limitation of this study was the variability across and within teams in terms of
PCL administration. Early on some teams were identified as administering the PCL incorrectly,
and while this was addressed – on average, most teams did not regularly administer the PCL.

65

Similarly, AUS and DUS scores were not reported by the same clinician necessarily each month,
which brings into question the validity of these scores. It is possible that some clinicians would
rate consumers differently based on their individual relationships with the consumers. With this,
also comes the concern that Non-Master Teams may have been reporting consumer outcomes
more positively than was the case to better represent themselves. While this is also possible for
Master Teams, given that Master Teams appeared more conscientious and agreeable than NonMaster Teams, it is possible that Master Teams were more likely to report themselves accurately
because of their proclivity to follow the rules.
The most glaring limitation of this study was that teams self-selected into the Master
group. Thus, the impact of the Master calls could not be isolated due to this self-selection bias.
Thus, it is unclear how much if at all the Master calls increased the use of ICBT or whether selfselected teams were innately more motivated to provide ICBT. Furthermore, factors such as staff
motivation, sense of obligation or stage in one’s career could have greater predictor’s of selfselection and ICBT use. Individuals who participated in the Master training appeared more
motivated and responsive to the project coordinator than clinicians who did not receive the
Master training. At the same time there were large differences in the amount of ICBT provided
by Master and Non-Master Teams that do not seem to have only been explained by motivation.
Instead, it appears that staff motivation had some type of additive effect on ICBT sessions
provided when paired with the additional training. However, since our groups were self-selected
and motivation was not formally assessed, there is no way to determine if there was in fact an
additive effect of combining training with motivation.
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Study Implications and Significance
While the data from this study are limited in many ways, the study has indicated the
importance of staff motivation on training outcomes and the role in which supervisory calls posttraining can add to treatment implementation. Even though Master Teams received more
training, their treatment implementation outcomes seem influenced by treatment team members
motivation. However, it does seem as though the additional training did provide a booster to
Master Teams. Furthermore, given that most implementation studies do not include client level
data and this one did, the impact of training on client outcomes seems minimal while the
provision of added ICBT seems somewhat beneficial for alcohol and PTSD score.
An additional finding of this study that may impact future work with ACT Teams is the
evidence that teams who volunteered for advanced training had fewer AOT clients. This finding
implies that there may be a benefit to ensuring AOT consumers are more equally distributed
across teams and/or fewer consumers are served by teams with these consumers. AOT
consumers pose a large administrative and clinical time addition to ACT Team therapists. This
study, thus demonstrates how that time addition can decrease motivation for additional training.
If teams have more administrative and clinical tasks, it may help the system to equally distribute
ACT consumers across teams city-wide.
AOT appeared to be one element of this work that was ICBT prohibitive, however, more
broadly, clinician uptake of ICBT really demonstrated the difficulties inherent in bringing EBPs
to real world settings. While the study findings were mixed, teams regularly complained about
providing ICBT, thought their consumers were too sick for ICBT and did not want to collect
consumer level data despite benefits to patients. This reality demonstrates the ways in which
patience and attention are extremely important in implementing EBPs in real world settings.
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Even though the study results were mixed, in the end many clinicians and consumers were
exposed to ICBT, which was the result of the training, on-going data collection and supervisory
calls. This exposure to ICBT likely had greater impact on the clinicians and consumers than this
study could demonstrate. However, it was clear in working with clinicians that continued support
around data collection and reminders of supervisory calls was pivotal in helping teams provide
ICBT.
Finally and perhaps most importantly, this work shows how difficult it is to successfully
implement an EBP training protocol in a real world behavioral health setting. Future work needs
to enlist support of teams and staff early on and before training to build motivation, understand
values related to treatment and find ways to easily and seamlessly incorporate a new practice into
an ongoing treatment setting. While, this study was able to accomplish getting a number of ACT
Team members interested in and using ICBT, many staff members felt resentful about the
implementation protocol and did not want to learn or provide ICBT. This study shows that while
efforts were made to keep ACT Teams in mind and work with them in a supportive way, that
motivation really needs to be better enhanced and understood to successfully implement EBPs.
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Chapter 6: Study Summary
Study Summary
This study examined the impact of added supervision on trauma training outcomes
among ACT Teams. While it was expected that teams receiving increased supervision would
provide ICBT more frequently and have better consumer outcomes, the results were mixed.
Overall, Master Teams did provide more ICBT sessions than Non-Master Teams however,
consumer outcomes were not always better for Master Teams and the extent to which the
supervisory calls impacted ICBT sessions provided is still unclear. What this study did seem to
demonstrate was the importance of staff motivation on training participation and treatment
implementation. In addition, the study hinted to the possible benefits of finding ways to increase
staff motivation through training in conjunction with added supervision and ICBT training.
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